Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 33
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Adopting mechanistic molecular biology approaches in exposome research for causal understanding

  • Foreman, Amy L.
  • Warth, Benedikt
  • Hessel, Ellen V. S.
  • Price, Elliott J.
  • Schymanski, Emma L.
  • Cantelli, Gaia
  • Parkinson, Helen
  • Hecht, Helge
  • Klánová, Jana
  • Vlaanderen, Jelle
  • Hilscherova, Klara
  • Vrijheid, Martine
  • Vineis, Paolo
  • Araujo, Rita
  • Barouki, Robert
  • Vermeulen, Roel
  • Lanone, Sophie
  • Brunak, Søren
  • Sebert, Sylvain
  • Karjalainen, Tuomo
Through investigating the combined impact of the environmental exposures experienced by an individual throughout their lifetime, exposome research provides opportunities to understand and mitigate negative health outcomes. While current exposome research is driven by epidemiological studies that identify associations between exposures and effects, new frameworks integrating more substantial population-level metadata, including electronic health and administrative records, will shed further light on characterizing environmental exposure risks. Molecular biology offers methods and concepts to study the biological and health impacts of exposomes in experimental and computational systems. Of particular importance is the growing use of omics readouts in epidemiological and clinical studies. This paper calls for the adoption of mechanistic molecular biology approaches in exposome research as an essential step in understanding the genotype and exposure interactions underlying human phenotypes. A series of recommendations are presented to make the necessary and appropriate steps to move from exposure association to causation, with a huge potential to inform precision medicine and population health. This includes establishing hypothesis-driven laboratory testing within the exposome field, supported by appropriate methods to read across from model systems research to human., The contents of this paper arose from a collaborative workshop run in 2020 on “Connecting molecular biology and big data in humans to study the exposome” funded and coordinated by the Human Ecosystems Transversal Theme (European Molecular Biology Laboratory) and Inserm with support provided by HP and GC. Thanks go to participants Ewan Birney, Remy Slama, Naomi Allen, Marc Chadeau, Andreas Kortenkamp, William Bourguet, Samuli Ripatti, Marc Chadeau-Hyam, and Xavier Basagańa. S.B. acknowledges support from the Novo Nordisk Foundation (grants NNF17OC0027594 and NNF14CC0001). E.L.S. acknowledges funding support from the Luxembourg National Research Fund (FNR) for project A18/BM/12341006. E.J.P., H.H., J.K., and K.H. acknowledge the research infrastructure RECETOX RI (LM2023069), H2020 CETOCOEN Excellence 857560, and OP RDE CZ.02.1.01/0.0/0.0/17_043/0009632. E.L.S. acknowledges funding support from the Luxembourg National Research Fund (FNR) for project A18/BM/12341006. This publication reflects only the authors’ views, and the European Commission is not responsible for any use that may be made of the information it contains.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Heat-related mortality in Europe during 2024 and health emergency forecasting to reduce preventable deaths

  • Janoš, Tomáš
  • Quijal-Zamorano, Marcos
  • Shartova, Natalia
  • Gallo, Elisa
  • Méndez Turrubiates, Raúl Fernando
  • Beltrán Barrón, Nadia Denisse
  • Peyrusse, Fabien
  • Ballester, Joan
Successive record-breaking summer temperatures, both globally and in Europe, raise the urgent question of how to better protect vulnerable populations. Here we quantified the heat-related mortality burden during the summers of 2022-2024, and assessed the forecast skill of a new generation of continental-wide, impact-based early warning systems during health emergencies. We fitted epidemiological models with the newly created, format-homogeneous daily mortality database of the EARLY-ADAPT project, covering 654 contiguous regions across 32 European countries, which represents the entire urban and rural population of 539 million people. We estimated 62,775 (95% confidence interval = 36,765-84,379) heat-related deaths in 2024, largely exceeding the burden in 2023 (50,798; 29,442-68,610), but somewhat smaller than that of 2022 (67,873; 38,465-92,455). We demonstrated that health emergencies can be forecast with high confidence at least 1 week in advance, even for highly vulnerable regions and population subgroups. These findings have implications for public health agencies and end users, given that the adoption of the system would enable reliable heat-health emergency alerts within the time window that is relevant for stakeholders to take effective actions to reduce preventable deaths., M.Q.-Z., N.S., E.G., R.F.M.T., N.D.B.B., F.P. and J.B. gratefully acknowledge funding from the European Union’s Horizon 2020 and Horizon Europe research and innovation programs (grant agreements 865564—European Research Council Consolidator Grant EARLY-ADAPT, https://www.early-adapt.eu/; 101069213—European Research Council Proof-of-Concept HHS-EWS, https://forecaster.health/ and 101123382—European Research Council Proof-of-Concept FORECAST-AIR). E.G. and J.B. additionally acknowledge funding from the European Union’s Horizon Europe research and innovation program (grant agreement 101057131—Horizon Europe project CATALYSE, https://catalysehorizon.eu/). ISGlobal authors acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. All authors acknowledge the use of ECMWF data from ERA5-Land and the Integrated Forecasting System. This work was supported by OP JAC—Project MSCAfellow7_MUNI (CZ.02.01.01/00/22_010/0008854) financed by the Ministry of Education, Youth and Sports—co-funded by the European Union. RECETOX authors thank the RECETOX Research Infrastructure (LM2023069), financed by the Ministry of Education, Youth and Sports, for its supportive background. This work was supported by the European Union’s Horizon 2020 research and innovation program (grant agreement 857560—CETOCOEN Excellence). This publication reflects only the author’s view, and the European Commission is not responsible for any use that may be made of the information it contains.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

External exposome and incident asthma across the life course in 14 European cohorts: a prospective analysis within the EXPANSE project

  • Yu, Zhebin
  • Dadvand, Payam
  • Tonne, Cathryn
  • EXPANSE Project Team
Background: The joint impact of exposure to multiple urban environmental factors on asthma remains unclear. Methods: We analysed data from 14 European cohorts to assess the impact of the urban exposome on asthma incidence across the life course. We linked three external exposome domains (air pollution, built environment, ambient temperature) to the participants’ home addresses at baseline. We performed k-means clustering within each domain and assessed associations of clusters with asthma adjusting for potentially relevant covariates in cohort-specific analyses, with subsequent separate meta-analyses for birth and adult cohorts. An environmental risk score using a coefficient-weighted sum approach was used to assess the impact of combining the three domains. Findings: A total of 7428 incident asthma cases were identified among 349,037 participants (from birth up to age 70+). Overall, we observed higher risks of asthma for clusters characterized by high particulate matter and nitrogen dioxide exposure in adults (ORmeta = 1.13, 95%CI:1.01–1.25), and clusters characterized by high built-up area and low levels of greenness in both children and adults (ORmeta = 1.36, 95%CI: 1.14–1.64 for birth cohorts and ORmeta = 1.15, 95%CI: 1.03–1.28 for adult cohorts, respectively). The joint exposure using the environment risk score combining the three domains was consistently associated with higher risks of incident asthma (ORmeta = 1.13, 95%CI: 1.07–1.20 for birth cohorts, ORmeta = 1.15, 95%CI: 1.10–1.20 for adult cohorts per 20% increase). On average 11.6% of the incident asthma cases could be attributed to environmental risk score above cohort-specific median levels. Interpretation: Multiple environmental exposures jointly contribute to incident asthma risk across the life course. Urban planning accounting for these factors may help mitigate asthma development. Funding: This study was funded by the European Union’s Horizon 2020 research and innovation program under agreement No 874627 (EXPANSE)., This study was funded by the European Union’s Horizon 2020 research and innovation program under agreement No 874627 (EXPANSE) and No 857560 (CETOCOEN Excellence). ZY is funded by the Swedish Research Council (VR No. 2024-02345) and Swedish Research Council for Health, Working life and Welfare (Forte No. 2023-01213). AS has received funding from the Swiss National Science Foundation (grant number 210781). MS received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 949906). PD and CT acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. Cohort-specific fundings are presented in the Supplementary materials. Authors thank the RECETOX Research Infrastructure (No LM2023069) financed by the Ministry of Education, Youth and Sports for supportive background. EM reports grants from Swedish Research Council (2024-03164), The Swedish Heart-Lung Foundation and Region Stockholm (ALF).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Firefighters and the liver: Exposure to PFAS and PAHs in relation to liver function and serum lipids (CELSPAC-FIREexpo study)

  • Pálešová, Nina
  • Maitre, Léa
  • Stratakis, Nikos
  • Řiháčková, Katarína
  • Pindur, Aleš
  • Kohoutek, Jir̂í
  • Šenk, Petr
  • Bartošková Polcrová, Anna
  • Gregor, Petr
  • Vrijheid, Martine
  • Čupr, Pavel
Introduction: Firefighting is one of the most hazardous occupations due to exposure to per- and polyfluoroalkyl substances (PFAS) and polycyclic aromatic hydrocarbons (PAHs). Such exposure is suspected to affect the cardiometabolic profile, e.g., liver function and serum lipids. However, only a few studies have investigated the impact of this specific exposure among firefighters. Methods: Men included in the CELSPAC-FIREexpo study were professional firefighters (n = 52), newly recruited firefighters in training (n = 58), and controls (n = 54). They completed exposure questionnaires and provided 1-3 samples of urine and blood during the 11-week study period to allow assessment of their exposure to PFAS (6 compounds) and PAHs (6 compounds), and to determine biomarkers of liver function (alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and total bilirubin (BIL)) and levels of serum lipids (total cholesterol (CHOL), low-density lipoprotein cholesterol (LDL) and triglycerides (TG)). The associations between biomarkers were investigated both cross-sectionally using multiple linear regression (MLR) and Bayesian weighted quantile sum (BWQS) regression and prospectively using MLR. The models were adjusted for potential confounders and false discovery rate correction was applied to account for multiplicity. Results: A positive association between exposure to PFAS and PAH mixture and BIL (β = 28.6%, 95% CrI = 14.6-45.7%) was observed by the BWQS model. When the study population was stratified, in professional firefighters and controls the mixture showed a positive association with CHOL (β = 29.5%, CrI = 10.3-53.6%) and LDL (β = 26.7%, CrI = 8.3-48.5%). No statistically significant associations with individual compounds were detected using MLR. Conclusions: This study investigated the associations between exposure to PFAS and PAHs and biomarkers of cardiometabolic health in the Czech men, including firefighters. The results suggest that higher exposure to a mixture of these compounds is associated with an increase in BIL and the alteration of serum lipids, which can result in an unfavourable cardiometabolic profile., This work was funded by the European Union's Horizon 2020 research and innovation program under grant agreement No 857487 and supported under grant agreement No 857340, grant agreement No 857560 and grant agreement No 874627. This work was supported by the project National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, ID Project No. LX22NPO5104) - Funded by the European Union – Next Generation EU. This work was supported by the European Union's Horizon Europe research and innovation programme in the framework of the European Partnership for the Assessment of Risks from Chemicals (PARC) under grant agreement No 101057014. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Advancing tools for human early lifecourse exposome research and translation (ATHLETE): Project overview

  • Vrijheid, Martine
  • Basagaña Flores, Xavier
  • González, Juan Ramón
  • Porcel, Joana
  • Bustamante Pineda, Mariona
  • Casas Sanahuja, Maribel
  • Dadvand, Payam
  • Fossati, Serena
  • Guxens Junyent, Mònica
  • Maitre, Léa
  • Nieuwenhuijsen, Mark J.
  • Ortiz, Rodney
  • Stratakis, Nikos
  • Sunyer Deu, Jordi
  • Slama, Rémy
Early life stages are vulnerable to environmental hazards and present important windows of opportunity for lifelong disease prevention. This makes early life a relevant starting point for exposome studies. The Advancing Tools for Human Early Lifecourse Exposome Research and Translation (ATHLETE) project aims to develop a toolbox of exposome tools and a Europe-wide exposome cohort that will be used to systematically quantify the effects of a wide range of community- and individual-level environmental risk factors on mental, cardiometabolic, and respiratory health outcomes and associated biological pathways, longitudinally from early pregnancy through to adolescence. Exposome tool and data development include as follows: (1) a findable, accessible, interoperable, reusable (FAIR) data infrastructure for early life exposome cohort data, including 16 prospective birth cohorts in 11 European countries; (2) targeted and nontargeted approaches to measure a wide range of environmental exposures (urban, chemical, physical, behavioral, social); (3) advanced statistical and toxicological strategies to analyze complex multidimensional exposome data; (4) estimation of associations between the exposome and early organ development, health trajectories, and biological (metagenomic, metabolomic, epigenetic, aging, and stress) pathways; (5) intervention strategies to improve early life urban and chemical exposomes, co-produced with local communities; and (6) child health impacts and associated costs related to the exposome. Data, tools, and results will be assembled in an openly accessible toolbox, which will provide great opportunities for researchers, policymakers, and other stakeholders, beyond the duration of the project. ATHLETE's results will help to better understand and prevent health damage from environmental exposures and their mixtures from the earliest parts of the life course onward., ISGlobal acknowledges support from the Spanish Ministry of Science, Innovation and Universities through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S) and support from the Generalitat de Catalunya through the Centres de Recerca de Catalunya Program. We acknowledge collaboration with European projects, specifically: Human Early Life Exposome (HELIX) (FP7 grant agreement number 308333), LifeCycle (H2020 grant agreement number 733206), and Connecting Europe and Canada in personalized health (EUCAN-Connect) (H2020 Grant Agreement number 824989). The Born in Bradford (BiB) cohort is only possible because of the enthusiasm and commitment of the Children and Parents in BiB. We are grateful to all the participants, health professionals, and researchers who have made BiB happen. The BiB cohort is only possible because of the enthusiasm and commitment of the children and parents in BiB. We are grateful to all the participants, health professionals, schools, and researchers who have made BiB happen. BiB has received funding from the Wellcome Trust (101597), a joint grant from the UK Medical Research Council and UK Economic and Social Science Research Council (MR/N024391/1), a British Heart Foundation Clinical Study grant (CS/16/4/32482). The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We are grateful to all the participating families in Norway who take part in this ongoing cohort study. The Danish National Birth Cohort was established with a significant grant from the Danish National Research Foundation. Additional support was obtained from the Danish Regional Committees, the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Health Foundation, and other minor grants. The Danish National Birth Cohort Biobank has been supported by the Novo Nordisk Foundation and the Lundbeck Foundation. Follow-up of mothers and children have been supported by the Danish Medical Research Council (SSVF 0646, 271-08-0839/06-066023, O602-01042B, 0602-02738B); the Lundbeck Foundation (195/04, R100-A9193); The Innovation Fund Denmark 0603-00294B (09-067124); the Nordea Foundation (02-2013-2014); Aarhus Ideas (AU R9-A959-13-S804); University of Copenhagen Strategic Grant (IFSV 2012); and the Danish Council for Independent Research (DFF—4183-00594 and DFF—4183-00152). The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Center, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport, and Ministry of Youth and Families. This project received funding from the European Union’s Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement number 733206, 2016; EUCAN-Connect grant agreement number 824989; ATHLETE, grant agreement number 874583). We gratefully acknowledge the contribution of participants, research collaborators, general practitioners, hospitals, midwives, and pharmacies in Rotterdam. The INfancia y Medio Ambiente cohort (INMA) Sababell study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. Fondo Europeo de Desarollo Regional (FEDER) funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds; PI15/00118 incl. FEDER funds; CP16/00128 incl. FEDER funds; PI16/00118 incl. FEDER funds; PI16/00261 incl. FEDER funds; PI17/01340 incl. FEDER funds, PI18/00547 incl. FEDER funds, PI20/01695 incl. FEDER funds), Centro de Investigación Biomédica en Red - Epidemiología y Salud Pública (CIBERESP), Generalitat de Catalunya-Comissió Interdepartamental de Recerca i Innovació Tecnològia 1999SGR 00241, Generalitat de Catalunya-Agencia de Gestión de Ayudas Universitarias y de Investigación (2009 SGR 501, 2014 SGR 822), Fundació La Marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds), Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010; EST-2016 RF-21, EST-19 RF-04), and the European Commission (261357, 308333, 603794 and 634453). The INMA Valencia study was supported by grants from Instituto de Salud Carlos III (FIS-FEDER: 13/2032, 13/1944, 14/00891, 16/1288, 17/00663, and 19/1338; Miguel Servet-FSE: CP15/0025 and MSII16/00051, 00051, and MSII20/0006), Alicia Koplowitz Foundation 2017, Generalitat Valenciana (AICO/2020/285), and Spanish Association Against Cancer (AECC) “Seed Ideas” 2019 (IDEAS19098LOPE). INMA Gipuzkoa was funded by grants from Instituto de Salud Carlos III (FIS-PI06/0867, FIS-PI09/00090, FIS-PI13/02187, and FIS-PI18/01142 incl. FEDER funds), CIBERESP, Department of Health of the Basque Government (2005111093, 2009111069, 2013111089, and 2015111065), and the Provincial Government of Gipuzkoa (DFG06/002, DFG08/001, and DFG15/221) and annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain). The Sepages cohort would like to thank the Grenoble University Hospital (CHU-GA) biobank (bb-0033-00069). We thank the Sepages Study group (E. Eyriey, P. Hoffmann, E. Hullo, J. Lepeule, C. Llerena, S. Lyon-Caen, X. Morin, A. Morlot, C. Philippat, I. Pin, J. Quentin, V. Siroux, R. Slama) and the participants of the Suivi de l’Exposition à la Pollution Atmosphérique durant la Grossesse et Effets sur la Santé (SEPAGES) study. We acknowledge support from Auvergne-Rhône-Alpes Région, Soutien aux coopérations universitaires et scientifiques internationales fund to support collaborations between Catalunya and Auvergne-Rhône-Alpes. SEPAGES cohort was supported by the European Research Council (consolidator grant N 311765-E-DOHaD, Principal Investigator [PI], R. Slama), by French National Research Agency (ANR), the ANR (Pregnancy, Air Pollution, Epigenetics and Respiratory health project ANR-12-PDOC-0029-01, PI, J. Lepeule; A Longitudinal Analysis of Effects of Early Life Exposure to Phenols on Health in Humans project, 14-CE21-0007-01, PI, R. Slama; Gut Microbiota in early childhood and Maternal Environmental exposures project, PI, R. Slama; Prenatal Exposure to Tobacco smoking and Air Pollution and Effects on offspring respiratory and neurodevelopmental outcomes ANR 18-CE36-005, PI, J. Lepeule). The Central European Longitudinal Study of Pregnacy and Childhood: The Next Generation (TNG) cohort is supported by the RECETOX research infrastructure (the Ministry of Education, Youth and Sports of the Czech Republic: LM2018121) and the CETOCOEN EXCELLENCE Teaming 2 project of European Union (EU) Horizon 2020 (857560) and the MEYS of the Czech Republic (02.1.01/0.0/0.0/18_ 046/0015975). The Barcelona Life Study Cohort has received funding from European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme under grant agreement number (785994) (Prenatal exposure to urban air pollution and pre and post-natal brain development project) and from the Health Effects Institute (HEI) under Agreement number 4959-RFPA15-1/18-1 (FRONTIER project). Genotyping in the HELIX study was supported by project PI17/01225 (Instituto de Salud Carlos III, co-funded by European Union [European Regional Development Fund], “A way to make Europe”) and the Centro Nacional de Genotipado-CEGEN (PRB2-ISCIII). The Nascita e Infanzia: gli Effetti dell’Ambiente cohort was partially funded by the Compagnia SanPaolo Foundation and the Piedmont Region. The Piccolipiù project was funded by the Italian National Center for Disease Prevention and Control (National Centre for Disease Prevention and Control grants years 2010 and 2014) and by the Italian Ministry of Health (art 12 and 12 bis D.lgs 502/92). The Perturbateurs Endocriniens: Étude Longitudinale sur les Anomalies de la Grossesse, l’Infertilité et l’Enfance study is supported by National Institute of Health and Medical Research and has received multiple funds from the ANR, the French Agency for Food, Environmental and Occupational Health and Safety (ANSES), the Fondation de France, the National Institute for Public Health Surveillance (InVS), the French, Ministry of Labor, the French Ministry of Health, and the French Ministry of Ecology. DataSHIELD is funded under a group of projects that underpin a program of development and application of secure methods for co-analysis, data sharing, and visualization in the Population Health Sciences Institute at Newcastle University (United Kingdom). These include: the “Connected Health Cities project” (North East and North Cumbria) funded by the UK Department of Health (RES/0150/7943/202); the “EUCanConnect project” (European Commission H2020 Flagship Collaboration with Canada); the “58FORWARDS project” (Fostering new Opportunities for Researchers via Wider Access to Research Data and Samples) funded jointly by the Wellcome Trust and the Medical Research Council (108439/Z/15/Z); and the “METADAC project” (Managing Ethico-social, Technical and Administrative issues in Data ACcess) funded jointly by the Medical Research Council, the Wellcome Trust, and the Economic and Social Research Council (MR/N01104X/1 and MR/N01104X/2). We acknowledge the Molecular Genetics Information System team, including Fleur Kelpin, Tommy de Boer, Mariska Slofstra, Connor Stroomberg, Jelmer Veen, Jeroen van Veen, Fernanda de Andrade, Marije van der Geest, Dieuwke Roelofs-Prins, Dennis Hendriksen, Bart Charbon, Joeri van der Velde, Max Postema, Erik Schaberg, Christiaan Hilbrands, Alexander Kellmann, and Luuk Dijkhuis.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Investigating exposure and hazards of micro- and nanoplastics during pregnancy and early life (AURORA Project): Protocol for an interdisciplinary study

  • Durkin, Amanda M.
  • Bustamante Pineda, Mariona
  • Dadvand, Payam
  • Vrijheid, Martine
  • Vermeulen, Roel
Background: Micro- and nanoplastics (MNPs) are emerging pollutants of concern with ubiquitous presence in global ecosystems. MNPs pose potential implications for human health; however, the health impacts of MNP exposures are not yet understood. Recent evidence suggests that MNPs can cross the placental barrier, underlying the urgent need to understand their impact on reproductive health and development. Objective: The Actionable eUropean ROadmap for early-life health Risk Assessment of micro- and nanoplastics (AURORA) project will investigate MNP exposures and their biological and health effects during pregnancy and early life, which are critical periods due to heightened vulnerability to environmental stressors. The AURORA project will enhance exposure assessment capabilities for measuring MNPs, MNP-associated chemicals, and plastic additives in human tissues, including placenta and blood. Methods: In this interdisciplinary project, we will advance methods for in-depth characterization and scalable chemical analytical strategies, enabling high-resolution and large-scale toxicological, exposure assessment, and epidemiological studies. The AURORA project performs observational studies to investigate determinants and health impacts of MNPs by including 800 mother-child pairs from 2 existing birth cohorts and 110 women of reproductive age from a newly established cohort. This will be complemented by toxicological studies using a tiered-testing approach and epidemiological investigations to evaluate associations between maternal and prenatal MNP exposures and health perturbations, such as placental function, immune-inflammatory responses, oxidative stress, accelerated aging, endocrine disruption, and child growth and development. The ultimate goal of the AURORA project is to create an MNP risk assessment framework and identify the remaining knowledge gaps and priorities needed to comprehensively assess the impact of MNPs on early-life health. Results: In the first 3 years of this 5-year project (2021-2026), progress was made toward all objectives. This includes completion of recruitment and data collection for new and existing cohorts, development of analytical methodological protocols, and initiation of the toxicological tiered assessments. As of September 2024, data analysis is ongoing and results are expected to be published starting in 2025. Conclusions: As plastic pollution increases globally, it is imperative to understand the impact of MNPs on human health, particularly during vulnerable developmental stages such as early life. The contributions of the AURORA project will inform future risk assessment. International registered report identifier (irrid): DERR1-10.2196/63176., The authors attest that there was no use of generative artificial intelligence technology in the generation of text, figures, or other informational content of this manuscript. This research was supported by funding from the European Union’s Horizon 2020 research and innovation programme (grant 964827; AURORA project, coordinated by University Medical Center Utrecht). RECETOX was supported by the European Union’s Horizon 2020 research and innovation programme (grant 857560; CETOCOEN Excellence).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The 2026 Europe report of the Lancet Countdown on health and climate change: narrowing window for decisive health action

  • Kriit, Hedi K.
  • Chen-Xu, José
  • Achebak, Hicham
  • Alari, Anna
  • Alcayna, Tilly
  • Ball, Emily
  • Ballester, Joan
  • Cirach, Marta
  • Janoš, Tomáš
  • Nieuwenhuijsen, Mark J.
  • Shartova, Natalia
  • Stucki, Lara
  • Antó i Boqué, Josep Maria
  • Tonne, Cathryn
  • Rocklöv, Joacim
We thank the global Lancet Countdown and the Wellcome Trust (grant number 304972/Z/23/Z) for their financial and technical support. We acknowledge funding from the EU's Horizon Europe research and innovation programme under grant agreement numbers 101057131 (Horizon Europe project CATALYSE), 101057554 (Horizon Europe project IDAlert), 101057690 (Horizon Europe project CLIMOS), and UK Research and Innovation grant agreements numbers 10041512, 10038150, and 10039289. We thank the EU Climate Change and Health Cluster, which includes the CATALYSE, IDAlert, and CLIMOS grants. KRvD acknowledges a fellowship from the British Heart Foundation Cambridge Centre for Research Excellence (number RE/24/130011). TA acknowledges support from the Norwegian Red Cross and the Norwegian Ministry of Foreign Affairs. RH and MSo acknowledge funding from Research Council of Finland for Vegetation Fires and Smoke Pollution Warning and Advisory System for Europe (grant 359421) and the EU Horizon projects FirEUrisk (grant 101003890) and ClimAir (grant 101156799). JP acknowledges funding for EU Horizon project SYLVA (grant 101086109) and Research Council of Finland project SPORELIFE (grant 355851). GECC acknowledges joint centre funding from the UK Medical Research Council and the Department for International Development (grant MR/R0156600/1). GECC and DL were supported by the Barcelona Supercoming Center AI4Science Fellowship programme funded by the Recovery and Resilience Mechanism-Next Generation as part of the Spanish Ministry's Recovery, Transformation and Resilience Plan. TR, JCM, and MC acknowledge support from Wellcome Trust (PATHFINDER2, grant number 313586/Z/24/Z and DESTINY, grant number 227165/Z/23/Z) and gratefully acknowledge the Ministry of Research, Science and Culture of Land Brandenburg for supporting this project by providing resources on the high-performance computer system at the Potsdam Institute for Climate Impact Research (grant number 22-Z105-05/002/001). TJ gratefully acknowledges support from OP JAC - Project MSCAfellow7_MUNI (number CZ.02·01·01/00/22_010/0008854) financed by the Czech Republic's Ministry of Education, Youth and Sports and co-funded by the EU, support from the EU's Horizon 2020 research and innovation programme under grant agreement number 857560 (CETOCOEN Excellence), and the RECETOX Research Infrastructure (number LM2023069), financed by the Czech Republic's Ministry of Education, Youth and Sports, for supportive background. JB, HA, and NS gratefully acknowledge funding from the EU's Horizon 2020 and Horizon Europe research and innovation programmes under grant agreements 865564 (European Research Council Consolidator Grant EARLY-ADAPT), 101069213 (European Research Council Proof-of-Concept HHS-EWS), and 101123382 (European Research Council Proof-of-Concept FORECAST-AIR). ISGlobal authors JC-X, HA, AA, JB, MC, TJ, MNie, NS, LS, JMA, and CT acknowledge support from grant CEX2023–0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. JM-U and JT acknowledge the funding of the Ministerio de Ciencia e Innovación (Spain) grant number PID2024–159955NB-I00. RL acknowledges a Royal Society Dorothy Hodgkin Fellowship and the EU's Horizon Europe research and innovation programme (E4Warning, grant agreement 101086640, and IDAlert, grant agreement 101057554). We thank Herbert Kruitbosch, David Patterson, and Elmeri Niemi for their contribution to the production of the new litigation indicator. We thank Yasna Palmeiro Silva for the support provided for the adaptation indicators (2.1.1, 2.1.2, and 2.2.1). We thank Oliver Schmoll and Vladimir Kenodrowski, from WHO's Regional Office for Europe, for their continuous engagement with the Lancet Countdown Europe Report 2026. The views expressed here are those of the authors, and the European Commission is not responsible for any use that may be made of the information it contains.
Repisalud
Publicación Artículo científico (JournalArticle)

Personal care product use and lifestyle affect phthalate and DINCH metabolite levels in teenagers and young adults

  • Stuchlík Fišerová, Petra
  • Melymuk, Lisa
  • Komprdová, Klára
  • Domínguez-Romero, Elena
  • Scheringer, Martin
  • Kohoutek, Jiří
  • Přibylová, Petra
  • Andrýsková, Lenka
  • Piler, Pavel
  • Koch, Holger M
  • Zvonař, Martin
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Klánová, Jana
Humans are widely exposed to phthalates and their novel substitutes, and considering the negative health effects associated with some phthalates, it is crucial to understand population levels and exposure determinants. This study is focused on 300 urine samples from teenagers (aged 12-17) and 300 from young adults (aged 18-37) living in Czechia collected in 2019 and 2020 to assess 17 plasticizer metabolites as biomarkers of exposure. We identified widespread phthalate exposure in the study population. The diethyl phthalate metabolite monoethyl phthalate (MEP) and three di (2-ethylhexyl) phthalate metabolites were detected in the urine of >99% of study participants. The highest median concentrations were found for metabolites of low-molecular-weight (LMW) phthalates: mono-n-butyl phthalate (MnBP), monoisobutyl phthalate (MiBP) and MEP (60.7; 52.6 and 17.6 μg/L in young adults). 1,2-cyclohexanedicarboxylic acid diisononyl ester (DINCH) metabolites were present in 68.2% of the samples with a median of 1.24 μg/L for both cohorts. Concentrations of MnBP and MiBP were similar to other European populations, but 5-6 times higher than in populations in North America. We also observed large variability in phthalate exposures within the study population, with 2-3 orders of magnitude differences in urinary metabolites between high and low exposed individuals. The concentrations varied with season, gender, age, and lifestyle factors. A relationship was found between high levels of MEP and high overall use of personal care products (PCPs). Cluster analysis suggested that phthalate exposures depend on season and multiple lifestyle factors, like time spent indoors and use of PCPs, which combine to lead to the observed widespread presence of phthalate metabolites in both study populations. Participants who spent more time indoors, particularly noticeably during colder months, had higher levels of high-molecular weight phthalate metabolites, whereas participants with higher PCP use, particularly women, tended to have higher concentration of LMW phthalate metabolites.
Repisalud
Publicación Artículo científico (JournalArticle)

Assessment of exposure to pesticide mixtures in five European countries by a harmonized urinary suspect screening approach

  • Ottenbros, Ilse
  • Lebret, Erik
  • Huber, Carolin
  • Lommen, Arjen
  • Antignac, Jean-Philippe
  • Čupr, Pavel
  • Šulc, Libor
  • Mikeš, Ondřej
  • Szigeti, Tamás
  • Középesy, Szilvia
  • Martinsone, Inese
  • Martinsone, Žanna
  • Akulova, Lasma
  • Pardo, Olga
  • Fernández, Sandra F
  • Coscollá, Clara
  • Pedraza-Diaz, Susana
  • Krauss, Martin
  • Debrauwer, Laurent
  • Wagner, Kévin
  • Nijssen, Rosalie
  • Mol, Hans
  • Vitale, Chiara Maria
  • Klánová, Jana
  • Molina, Borja Garlito
  • León, Nuria
  • Vermeulen, Roel
  • Luijten, Mirjam
  • Vlaanderen, Jelle
Humans are exposed to a mixture of pesticides through diet as well as through the environment. We conducted a suspect-screening based study to describe the probability of (concomitant) exposure to a set of pesticide profiles in five European countries (Latvia, Hungary, Czech Republic, Spain and the Netherlands). We explored whether living in an agricultural area (compared to living in a peri-urban area), being a a child (compared to being an adult), and the season in which the urine sample was collected had an impact on the probability of detection of pesticides (-metabolites). In total 2088 urine samples were collected from 1050 participants (525 parent-child pairs) and analyzed through harmonized suspect screening by five different laboratories. Fourty pesticide biomarkers (either pesticide metabolites or the parent pesticides as such) relating to 29 pesticides were identified at high levels of confidence in samples across all study sites. Most frequently detected were biomarkers related to the parent pesticides acetamiprid and chlorpropham. Other biomarkers with high detection rates in at least four countries related to the parent pesticides boscalid, fludioxonil, pirimiphos-methyl, pyrimethanil, clothianidin, fluazifop and propamocarb. In 84% of the samples at least two different pesticides were detected. The median number of detected pesticides in the urine samples was 3, and the maximum was 13 pesticides detected in a single sample. The most frequently co-occurring substances were acetamiprid with chlorpropham (in 62 urine samples), and acetamiprid with tebuconazole (30 samples). Some variation in the probability of detection of pesticides (-metabolites) was observed with living in an agricultural area or season of urine sampling, though no consistent patterns were observed. We did observe differences in the probability of detection of a pesticide (metabolite) among children compared to adults, suggesting a different exposure and/or elimination patterns between adults and children. This survey demonstrates the feasibility of conducting a harmonized pan-European sample collection, combined with suspect screening to provide insight in the presence of exposure to pesticide mixtures in the European population, including agricultural areas. Future improvements could come from improved (harmonized) quantification of pesticide levels.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Current exposure to phthalates and DINCH in European children and adolescents - Results from the HBM4EU Aligned Studies 2014 to 2021

  • Vogel, Nina
  • Schmidt, Phillipp
  • Lange, Rosa
  • Gerofke, Antje
  • Sakhi, Amrit K
  • Haug, Line S
  • Jensen, Tina Kold
  • Frederiksen, Hanne
  • Szigeti, Tamás
  • Csákó, Zsófia
  • Palkovicova Murinova, Lubica
  • Šidlovská, Miroslava
  • Janasik, Beata
  • Wasowicz, Wojciech
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Gabriel, Catherine
  • Karakitsios, Spyros
  • Barbone, Fabio
  • Rosolen, Valentina
  • Rambaud, Loïc
  • Riou, Margaux
  • Murawski, Aline
  • Leseman, Daan
  • Koppen, Gudrun
  • Covaci, Adrian
  • Lignell, Sanna
  • Lindroos, Anna Karin
  • Zvonař, Martin
  • Andryskova, Lenka
  • Fábelová, Lucia
  • Richterová, Denisa
  • Horvat, Milena
  • Kosjek, Tina
  • Sarigiannis, Denis
  • Maroulis, Marios
  • Pedraza-Diaz, Susana
  • Cañas Portilla, Ana Isabel
  • Verheyen, Veerle J
  • Bastiaensen, Michiel
  • Gilles, Liese
  • Schoeters, Greet
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Govarts, Eva
  • Koch, Holger M
  • Kolossa-Gehring, Marike
Phthalates are mainly used as plasticizers for polyvinyl chloride (PVC). Exposure to several phthalates is associated with different adverse effects most prominently on the development of reproductive functions. The HBM4EU Aligned Studies (2014-2021) have investigated current European exposure to ten phthalates (DEP, BBzP, DiBP, DnBP, DCHP, DnPeP, DEHP, DiNP, DiDP, DnOP) and the substitute DINCH to answer the open policy relevant questions which were defined by HBM4EU partner countries and EU institutions as the starting point of the programme. The exposure dataset includes ∼5,600 children (6-11 years) and adolescents (12-18 years) from up to 12 countries per age group and covering the North, East, South and West European regions. Study data from participating studies were harmonised with respect to sample size and selection of participants, selection of biomarkers, and quality and comparability of analytical results to provide a comparable perspective of European exposure. Phthalate and DINCH exposure were deduced from urinary excretions of metabolites, where concentrations were expressed as their key descriptor geometric mean (GM) and 95th percentile (P95). This study aims at reporting current exposure levels and differences in these between European studies and regions, as well as comparisons to human biomonitoring guidance values (HBM-GVs). GMs for children were highest for ∑DEHP metabolites (33.6 μg/L), MiBP (26.6 μg/L), and MEP (24.4 μg/L) and lowest for∑DiDP metabolites (1.91 μg/L) and ∑DINCH metabolites (3.57 μg/L). In adolescents highest GMs were found for MEP (43.3 μg/L), ∑DEHP metabolites (28.8 μg/L), and MiBP (25.6 μg/L) and lowest for ∑DiDP metabolites (= 2.02 μg/L) and ∑DINCH metabolites (2.51 μg/L). In addition, GMs and P95 stratified by European region, sex, household education level, and degree of urbanization are presented. Differences in average biomarker concentrations between sampling sites (data collections) ranged from factor 2 to 9. Compared to the European average, children in the sampling sites OCC (Denmark), InAirQ (Hungary), and SPECIMEn (The Netherlands) had the lowest concentrations across all metabolites and ESTEBAN (France), NAC II (Italy), and CROME (Greece) the highest. For adolescents, comparably higher metabolite concentrations were found in NEB II (Norway), PCB cohort (Slovakia), and ESTEBAN (France), and lower concentrations in POLAES (Poland), FLEHS IV (Belgium), and GerES V-sub (Germany). Multivariate analyses (Survey Generalized Linear Models) indicate compound-specific differences in average metabolite concentrations between the four European regions. Comparison of individual levels with HBM-GVs revealed highest rates of exceedances for DnBP and DiBP, with up to 3 and 5%, respectively, in children and adolescents. No exceedances were observed for DEP and DINCH. With our results we provide current, detailed, and comparable data on exposure to phthalates in children and - for the first time - in adolescents, and - for the first time - on DINCH in children and adolescents of all four regions of Europe which are particularly suited to inform exposure and risk assessment and answer open policy relevant questions.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

Exposure to flame retardants in European children - Results from the HBM4EU aligned studies

  • van der Schyff, Veronica
  • Kalina, Jiři
  • Govarts, Eva
  • Gilles, Liese
  • Schoeters, Greet
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Kohoutek, Jiří
  • Kukučka, Petr
  • Covaci, Adrian
  • Koppen, Gudrun
  • Andrýsková, Lenka
  • Piler, Pavel
  • Klánová, Jana
  • Jensen, Tina Kold
  • Rambaud, Loïc
  • Riou, Margaux
  • Lamoree, Marja
  • Kolossa-Gehring, Marike
  • Vogel, Nina
  • Weber, Till
  • Göen, Thomas
  • Gabriel, Catherine
  • Sarigiannis, Dimosthenis A
  • Sakhi, Amrit Kaur
  • Haug, Line Småstuen
  • Palkovicova Murinova, Lubica
  • Fábelová, Lucia
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Melymuk, Lisa
Many legacy and emerging flame retardants (FRs) have adverse human and environmental health effects. This study reports legacy and emerging FRs in children from nine European countries from the HBM4EU aligned studies. Studies from Belgium, Czech Republic, Germany, Denmark, France, Greece, Slovenia, Slovakia, and Norway conducted between 2014 and 2021 provided data on FRs in blood and urine from 2136 children. All samples were collected and analyzed in alignment with the HBM4EU protocols. Ten halogenated FRs were quantified in blood, and four organophosphate flame retardants (OPFR) metabolites quantified in urine. Hexabromocyclododecane (HBCDD) and decabromodiphenyl ethane (DBDPE) were infrequently detected (<16% of samples). BDE-47 was quantified in blood from Greece, France, and Norway, with France (0.36 ng/g lipid) having the highest concentrations. BDE-153 and -209 were detected in <40% of samples. Dechlorane Plus (DP) was quantified in blood from four countries, with notably high median concentrations of 16 ng/g lipid in Slovenian children. OPFR metabolites had a higher detection frequency than other halogenated FRs. Diphenyl phosphate (DPHP) was quantified in 99% of samples across 8 countries at levels ∼5 times higher than other OPFR metabolites (highest median in Slovenia of 2.43 ng/g lipid). FR concentrations were associated with lifestyle factors such as cleaning frequency, employment status of the father of the household, and renovation status of the house, among others. The concentrations of BDE-47 in children from this study were similar to or lower than FRs found in adult matrices in previous studies, suggesting lower recent exposure and effectiveness of PBDE restrictions.
Repisalud
Publicación Artículo de revisión (ReviewArticle)

A critical review to identify data gaps and improve risk assessment of bisphenol A alternatives for human health

  • Mhaouty-Kodja, Sakina
  • Zalko, Daniel
  • Tait, Sabrina
  • Testai, Emanuela
  • Viguié, Catherine
  • Corsini, Emanuela
  • Grova, Nathalie
  • Buratti, Franca Maria
  • Cabaton, Nicolas J
  • Coppola, Lucia
  • De la Vieja, Antonio
  • Dusinska, Maria
  • El Yamani, Naouale
  • Galbiati, Valentina
  • Iglesias-Hernandez, Patricia
  • Kohl, Yvonne
  • Maddalon, Ambra
  • Marcon, Francesca
  • Naulé, Lydie
  • Rundén-Pran, Elise
  • Salani, Francesca
  • Santori, Nicoletta
  • Torres-Ruiz, Mónica
  • Turner, Jonathan D
  • Adamovsky, Ondrej
  • Aiello-Holden, Kiara
  • Dirven, Hubert
  • Louro, Henriqueta
  • Silva, Maria João
Bisphenol A (BPA), a synthetic chemical widely used in the production of polycarbonate plastic and epoxy resins, has been associated with a variety of adverse effects in humans including metabolic, immunological, reproductive, and neurodevelopmental effects, raising concern about its health impact. In the EU, it has been classified as toxic to reproduction and as an endocrine disruptor and was thus included in the candidate list of substances of very high concern (SVHC). On this basis, its use has been banned or restricted in some products. As a consequence, industries turned to bisphenol alternatives, such as bisphenol S (BPS) and bisphenol F (BPF), which are now found in various consumer products, as well as in human matrices at a global scale. However, due to their toxicity, these two bisphenols are in the process of being regulated. Other BPA alternatives, whose potential toxicity remains largely unknown due to a knowledge gap, have also started to be used in manufacturing processes. The gradual restriction of the use of BPA underscores the importance of understanding the potential risks associated with its alternatives to avoid regrettable substitutions. This review aims to summarize the current knowledge on the potential hazards related to BPA alternatives prioritized by European Regulatory Agencies based on their regulatory relevance and selected to be studied under the European Partnership for the Assessment of Risks from Chemicals (PARC): BPE, BPAP, BPP, BPZ, BPS-MAE, and TCBPA. The focus is on data related to toxicokinetic, endocrine disruption, immunotoxicity, developmental neurotoxicity, and genotoxicity/carcinogenicity, which were considered the most relevant endpoints to assess the hazard related to those substances. The goal here is to identify the data gaps in BPA alternatives toxicology and hence formulate the future directions that will be taken in the frame of the PARC project, which seeks also to enhance chemical risk assessment methodologies using new approach methodologies (NAMs).
Repisalud
Publicación Artículo científico (JournalArticle)

Harmonization and Visualization of Data from a Transnational Multi-Sensor Personal Exposure Campaign

  • Novak, Rok
  • Petridis, Ioannis
  • Kocman, David
  • Robinson, Johanna Amalia
  • Kanduč, Tjaša
  • Chapizanis, Dimitris
  • Karakitsios, Spyros
  • Flückiger, Benjamin
  • Vienneau, Danielle
  • Mikeš, Ondřej
  • Degrendele, Céline
  • Sáňka, Ondřej
  • Garcia Dos Santos-Alves, Saul
  • Maggos, Thomas
  • Pardali, Demetra
  • Stamatelopoulou, Asimina
  • Saraga, Dikaia
  • Persico, Marco Giovanni
  • Visave, Jaideep
  • Gotti, Alberto
  • Sarigiannis, Dimosthenis
Use of a multi-sensor approach can provide citizens with holistic insights into the air quality of their immediate surroundings and their personal exposure to urban stressors. Our work, as part of the ICARUS H2020 project, which included over 600 participants from seven European cities, discusses the data fusion and harmonization of a diverse set of multi-sensor data streams to provide a comprehensive and understandable report for participants. Harmonizing the data streams identified issues with the sensor devices and protocols, such as non-uniform timestamps, data gaps, difficult data retrieval from commercial devices, and coarse activity data logging. Our process of data fusion and harmonization allowed us to automate visualizations and reports, and consequently provide each participant with a detailed individualized report. Results showed that a key solution was to streamline the code and speed up the process, which necessitated certain compromises in visualizing the data. A thought-out process of data fusion and harmonization of a diverse set of multi-sensor data streams considerably improved the quality and quantity of distilled data that a research participant received. Though automation considerably accelerated the production of the reports, manual and structured double checks are strongly recommended.
Repisalud
Publicación Artículo científico (JournalArticle)

Cumulative risk assessment of five phthalates in European children and adolescents

  • Lange, Rosa
  • Vogel, Nina
  • Schmidt, Phillipp
  • Gerofke, Antje
  • Luijten, Mirjam
  • Bil, Wieneke
  • Santonen, Tiina
  • Schoeters, Greet
  • Gilles, Liese
  • Sakhi, Amrit K
  • Haug, Line S
  • Jensen, Tina K
  • Frederiksen, Hanne
  • Koch, Holger M
  • Szigeti, Tamás
  • Szabados, Máté
  • Tratnik, Janja Snoj
  • Mazej, Darja
  • Gabriel, Catherine
  • Sarigiannis, Dimosthenis
  • Dzhedzheia, Vazha
  • Karakitsios, Spyros
  • Rambaud, Loïc
  • Riou, Margaux
  • Koppen, Gudrun
  • Covaci, Adrian
  • Zvonař, Martin
  • Piler, Pavel
  • Klánová, Jana
  • Fábelová, Lucia
  • Richterová, Denisa
  • Kosjek, Tina
  • Runkel, Agneta
  • Pedraza-Diaz, Susana
  • Verheyen, Veerle
  • Bastiaensen, Michiel
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Kolossa-Gehring, Marike
The European Human Biomonitoring Initiative (HBM4EU) assessed human biomonitoring data on phthalates in children and adolescents, that were sampled between 2014 and 2021, in a harmonised way. These so-called “HBM4EU Aligned Studies” revealed that almost all children and adolescents were exposed to multiple phthalates concurrently. Some phthalates have been shown to act in a dose-additive manner, thus, a mixture risk assessment is warranted. In our study, we determine the risk from combined exposure to five anti-androgenic phthalates, namely DEHP, DiBP, DnBP, BBzP and DiNP by making use of the hazard index (HI) approach. Toxicologically-based human biomonitoring guidance values (HBM-GVs) derived within the framework of HBM4EU served as basis. Our results show that exposures of 17% of children and adolescents from twelve European countries resulted in hazard indices (HI) > 1 with an HI of 1.77 at the 95th percentile (geometric mean, GM = 0.44). Main drivers for the mixture risk are DnBP and DiBP. Generalized Linear Model (GLM) analysis including four major exposure determinants (age, sex, European region, sampling year) simultaneously reveal differences for the European regions and between sampling years. Children and adolescents living in the Eastern region of Europe have on average, higher HIs (GM=0.58) than in the Southern region (GM = 0.36) and Western region (GM = 0.42). Moreover, participants from which urine samples were taken in the earlier years (2014–2016) seem to have higher average HI levels than participants from studies with later sampling periods. Strikingly, the majority (63%) of participants with HIs > 1 would have gone unnoticed in single substance risk assessments as individual phthalates levels were below corresponding HBM-GVs. Thus, our results underline the importance of mixture risk assessment approaches to adequately address risks from concurrent chemical exposure.
Repisalud
Publicación Artículo científico (JournalArticle)

Cadmium exposure in adults across Europe: Results from the HBM4EU Aligned Studies survey 2014-2020

  • Snoj Tratnik, Janja
  • Kocman, David
  • Horvat, Milena
  • Andersson, Anna-Maria
  • Juul, Anders
  • Jacobsen, Eva
  • Ólafsdóttir, Kristin
  • Klánová, Jana
  • Andryskova, Lenka
  • Janasik, Beata
  • Wasowicz, Wojciech
  • Janev Holcer, Natasa
  • Namorado, Sónia
  • Coelho, Inês
  • Rambaud, Loïc
  • Riou, Margaux
  • Van Nieuwenhuyse, An
  • Appenzeller, Brice
  • Kolossa-Gehring, Marike
  • Weber, Till
  • Esteban-Lopez, Marta
  • Castaño, Argelia
  • Gilles, Liese
  • Rodriguez Marti, Laura
  • Schoeters, Greet
  • Sepai, Ovnair
  • Govarts, Eva
The objectives of the study were to estimate the current exposure to cadmium (Cd) in Europe, potential differences between the countries and geographic regions, determinants of exposure and to derive European exposure levels. The basis for this work was provided by the European Human Biomonitoring Initiative (HBM4EU) which established a framework for alignment of national or regional HBM studies. For the purpose of Cd exposure assessment, studies from 9 European countries (Iceland, Denmark, Poland, Czech Republic, Croatia, Portugal, Germany, France, Luxembourg) were included and urine of 20-39 years old adults sampled in the years 2014-2021 (n = 2510). The measurements in urine were quality assured by the HBM4EU quality assurance/quality control scheme, study participants' questionnaire data were post-harmonized. Spatially resolved external data, namely Cd concentrations in soil, agricultural areas, phosphate fertilizer application, traffic density and point source Cd release were collected for the respective statistical territorial unit (NUTS). There were no distinct geographic patterns observed in Cd levels in urine, although the data revealed some differences between the specific study sites. The levels of exposure were otherwise similar between two time periods within the last decade (DEMOCOPHES - 2011-2012 vs. HBM4EU Aligned Studies, 2014-2020). The age-dependent alert values for Cd in urine were exceeded by 16% of the study participants. Exceedances in the different studies and locations ranged from 1.4% up to 42%. The studies with largest extent of exceedance were from France and Poland. Association analysis with individual food consumption data available from participants' questionnaires showed an important contribution of vegetarian diet to the overall exposure, with 35% higher levels in vegetarians as opposed to non-vegetarians. For comparison, increase in Cd levels due to smoking was 25%. Using NUTS2-level external data, positive associations between HBM data and percentage of cropland and consumption of Cd-containing mineral phosphate fertilizer were revealed, which indicates a significant contribution of mineral phosphate fertilizers to human Cd exposure through diet. In addition to diet, traffic and point source release were identified as significant sources of exposure in the study population. The findings of the study support the recommendation by EFSA to reduce Cd exposure as also the estimated mean dietary exposure of adults in the EU is close or slightly exceeding the tolerable weekly intake. It also indicates that regulations are not protecting the population sufficiently.
Repisalud
Publicación Artículo científico (JournalArticle)

From science to policy: How European HBM indicators help to answer policy questions related to phthalates and DINCH exposure

  • Gerofke, Antje
  • David, Madlen
  • Schmidt, Phillipp
  • Lobo Vicenta, Joana
  • Buekers, Jurgen
  • Gilles, Liese
  • Colles, Ann
  • Bessems, Jos
  • Bastiaensen, Michiel
  • Covaci, Adrian
  • Den Hond, Elly
  • Koppen, Gudrun
  • Laeremans, Michelle
  • Verheyen, Veerle J
  • Černá, Milena
  • Klánová, Jana
  • Krskova, Andrea
  • Zvonař, Martin
  • Knudsen, Lisbeth E
  • Koch, Holger M
  • Jensen, Tina Kold
  • Rambaud, Loïc
  • Riou, Margaux
  • Vogel, Nina
  • Gabriel, Catherine
  • Karakitsios, Spyros
  • Papaioannou, Nafsika
  • Sarigiannis, Denis
  • Kakucs, Réka
  • Középesy, Szilvia
  • Rudnai, Péter
  • Szigeti, Tamás
  • Barbone, Fabio
  • Rosolen, Valentina
  • Guignard, Cedric
  • Gutleb, Arno C
  • Sakhi, Amrit Kaur
  • Haug, Line Småstuen
  • Janasik, Beata
  • Ligocka, Danuta
  • Eštóková, Milada
  • Fábelová, Lucia
  • Kolena, Branislav
  • Palkovicova Murinova, Lubica
  • Petrovičová, Ida
  • Richterová, Denisa
  • Horvat, Milena
  • Mazej, Darja
  • Tratnik, Janja Snoj
  • Runkel, Agneta Annika
  • Castaño, Argelia
  • Esteban-Lopez, Marta
  • Pedraza-Diaz, Susana
  • Åkesson, Agneta
  • Lignell, Sanna
  • Vlaanderen, Jelle
  • Zock, Jan-Paul
  • Schoeters, Greet
  • Kolossa-Gehring, Marike
Within the European Human Biomonitoring (HBM) Initiative HBM4EU we derived HBM indicators that were designed to help answering key policy questions and support chemical policies. The result indicators convey information on chemicals exposure of different age groups, sexes, geographical regions and time points by comparing median exposure values. If differences are observed for one group or the other, policy measures or risk management options can be implemented. Impact indicators support health risk assessment by comparing exposure values with health-based guidance values, such as human biomonitoring guidance values (HBM-GVs). In general, the indicators should be designed to translate complex scientific information into short and clear messages and make it accessible to policy makers but also to a broader audience such as stakeholders (e.g. NGO's), other scientists and the general public. Based on harmonized data from the HBM4EU Aligned Studies (2014-2021), the usefulness of our indicators was demonstrated for the age group children (6-11 years), using two case examples: one phthalate (Diisobutyl phthalate: DiBP) and one non-phthalate substitute (Di-isononyl cyclohexane-1,2- dicarboxylate: DINCH). For the comparison of age groups, these were compared to data for teenagers (12-18 years), and time periods were compared using data from the DEMOCOPHES project (2011-2012). Our result indicators proved to be suitable for demonstrating the effectiveness of policy measures for DiBP and the need of continuous monitoring for DINCH. They showed similar exposure for boys and girls, indicating that there is no need for gender focused interventions and/or no indication of sex-specific exposure patterns. They created a basis for a targeted approach by highlighting relevant geographical differences in internal exposure. An adequate data basis is essential for revealing differences for all indicators. This was particularly evident in our studies on the indicators on age differences. The impact indicator revealed that health risks based on exposure to DiBP cannot be excluded. This is an indication or flag for risk managers and policy makers that exposure to DiBP still is a relevant health issue. HBM indicators derived within HBM4EU are a valuable and important complement to existing indicator lists in the context of environment and health. Their applicability, current shortcomings and solution strategies are outlined.
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Application of AOPs to assist regulatory assessment of chemical risks – Case studies, needs and recommendations

  • Bajard, Lola
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Hernández Jérez, Antonio Francisco|||0000-0003-2983-5418
  • Mustieles Miralles, Vicente
While human regulatory risk assessment (RA) still largely relies on animal studies, new approach methodologies (NAMs) based on in vitro, in silico or non-mammalian alternative models are increasingly used to evaluate chemical hazards. Moreover, human epidemiological studies with biomarkers of effect (BoE) also play an invaluable role in identifying health effects associated with chemical exposures. To move towards the next generation risk assessment (NGRA), it is therefore crucial to establish bridges between NAMs and standard approaches, and to establish processes for increasing mechanistically-based biological plausibility in human studies. The Adverse Outcome Pathway (AOP) framework constitutes an important tool to address these needs but, despite a significant increase in knowledge and awareness, the use of AOPs in chemical RA remains limited. The objective of this paper is to address issues related to using AOPs in a regulatory context from various perspectives as it was discussed in a workshop organized within the European Union partnerships HBM4EU and PARC in spring 2022. The paper presents examples where the AOP framework has been proven useful for the human RA process, particularly in hazard prioritization and characterization, in integrated approaches to testing and assessment (IATA), and in the identification and validation of BoE in epidemiological studies. Nevertheless, several limitations were identified that hinder the optimal usability and acceptance of AOPs by the regulatory community including the lack of quantitative information on response-response relationships and of efficient ways to map chemical data (exposure and toxicity) onto AOPs. The paper summarizes suggestions, ongoing initiatives and third-party tools that may help to overcome these obstacles and thus assure better implementation of AOPs in the NGRA., European Commission 733032 857560 101057014, Ministry of Education, Youth and Sports by the RECETOX Research Infrastructure LM2018121, OP RDE project CETOCOEN Excellence CZ.02.1.01/0.0/0.0/17_043/0009632, Japan Agency for Medical Research and Development (AMED) JP21mk0101216 JP22mk0101216, Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), Japan Society for the Promotion of Science, Grants-in-Aid for Scientific Research (KAKENHI) 21K12133
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Endocrine disrupting potential of replacement flame retardants – Review of current knowledge for nuclear receptors associated with reproductive outcomes

  • Bajard, Lola
  • Mustieles Miralles, Vicente
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
The research was supported by funding from the European Unions ' Horizon 2020 Research and Innovation Programme under grant agreements No 733032 (HBM4EU) , No. 859891 (PRORISK) , and No. 857560 (CETOCOEN EXCELLENCE Teaming 2 project) . The RECETOX Research infrastructure was further supported by the Czech Ministry of Education, Youth and Sports (LM2018121; CZ02.1.01/0.0/0.0/18_046/0015975) ., Background and aim: Endocrine disrupting chemicals (EDCs) constitute a major public health concern because they can induce a large spectrum of adverse effects by interfering with the hormonal system. Rapid identification of potential EDCs using in vitro screenings is therefore critical, particularly for chemicals of emerging concerns such as replacement flame retardants (FRs). The review aimed at identifying (1) data gaps and research needs regarding endocrine disrupting (ED) properties of replacement FRs and (2) potential EDCs among these emerging chemicals. Methods: A systematic search was performed from open literature and ToxCast/Tox21 programs, and results from in vitro tests on the activities of 52 replacement FRs towards five hormone nuclear receptors (NRs) associated with reproductive outcomes (estrogen, androgen, glucocorticoid, progesterone, and aryl hydrocarbon receptors) were compiled and organized into tables. Findings were complemented with information from structure-based in silico model predictions and in vivo information when relevant. Results: For the majority of the 52 replacement FRs, experimental in vitro data on activities towards these five NRs were either incomplete (15 FRs) or not found (24 FRs). Within the replacement FRs for which effect data were found, some appeared as candidate EDCs, such as triphenyl phosphate (TPhP) and tris(1,3-dichloropropyl) phosphate (TDCIPP). The search also revealed shared ED profiles. For example, anti-androgenic activity was reported for 19 FRs and predicted for another 21 FRs. Discussion: This comprehensive review points to critical gaps in knowledge on ED potential for many replacement FRs, including chemicals to which the general population is likely exposed. Although this review does not cover all possible characteristics of ED, it allowed the identification of potential EDCs associated with reproductive outcomes, calling for deeper evaluation and possibly future regulation of these chemicals. By identifying shared ED profiles, this work also raises concerns for mixture effects since the population is co-exposed to several FRs and other chemicals., European Commission 733032 859891 857560, Ministry of Education, Youth & Sports - Czech Republic LM2018121 CZ02.1.01/0.0/0.0/18_046/0015975
Digibug. Repositorio Institucional de la Universidad de Granada
Publicación Artículo científico (JournalArticle)

Pyrethroids and developmental neurotoxicity - A critical review of epidemiological studies and supporting mechanistic evidence

  • Raun Andersen, Helle
  • Freire, Carmen
  • Fernández Cabrera, Mariana Fátima|||0000-0001-6417-8914
  • Reina Pérez, Iris
Background: Pyrethroid metabolites are widely detectable in urine from the general population, including pregnant women and children. Pyrethroids are neurotoxic and suggested endocrine disruptors. Exposure during vulnerable developmental time windows may have long-term impacts on neurodevelopment. Objective: To evaluate the epidemiological evidence for neurodevelopmental effects related to prenatal and childhood pyrethroid exposure in a systematic review and to assess biological plausibility by evaluating mechanistic evidence. Methods: We searched PubMed and Web of Science up to September 1, 2021 and included original studies published in English in which pyrethroid exposure was measured or estimated during pregnancy or childhood and associations with neurodevelopmental outcomes in the children were investigated. The Navigation Guide Systematic Review Methodology was used to evaluate the epidemiological evidence. For mechanistic evidence, we focused on relevant key events (KEs) suggested in Adverse Outcome Pathways (AOPs) using the OECDsupported AOP-wiki platform. A systematic search combining the KEs with pyrethroids, including 26 individual compounds, was performed in the ToxCast database. Results: Twenty-five epidemiological studies met the inclusion criteria, 17 presented findings on prenatal exposure, 10 on childhood exposure and two on both exposure windows. The overall body of evidence was rated as “moderate quality” with “sufficient evidence” for an association between prenatal pyrethroid exposure and adverse neurodevelopment. For childhood exposure, the overall rating was “low quality” with “limited evidence” because of cross-sectional study design. Regarding mechanistic evidence, we found that pyrethroids are able to interfere with neurodevelopmental KEs included in established AOPs for adverse neurodevelopmental. The evidence was strongest for interference with thyroid hormone (TH) function. Conclusion: Pyrethroids are probably human developmental neurotoxicants and adverse impacts of pyrethroid exposure on neurodevelopment are likely at exposure levels occurring in the general population. Preventive measures to reduce exposure among pregnant women and children are warranted., European Commission 733032 CZ.02.1.01/0.0/0.0/17_043/0009632, Ministry of Education, Youth and Sports, and Operational Programme Research, Development and Innovation - project CETOCOEN EXCELLENCE LM2018121, 857560
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Passive-Sampler-Derived PCB and OCP Concentrations in the Waters of the World─First Results from the AQUA-GAPS/MONET Network

  • Lohmann, Rainer
  • Vrana, Branislav
  • Muir, Derek
  • Smedes, Foppe
  • Sobotka, Jaromír
  • Zeng, Eddy Y
  • Bao, Lian-Jun
  • Allan, Ian J.
  • Astrahan, Peleg
  • Barra, Ricardo O.
  • Bidleman, Terry
  • Dykyi, Evgen
  • Estoppey, Nicolas
  • Fillmann, Gilberto
  • Greenwood, Naomi
  • Helm, Paul A.
  • Jantunen, Liisa
  • Kaserzon, Sarit
  • Macías, J Vinicio
  • Maruya, Keith A.
  • Molina, Francisco
  • Newman, Brent
  • Prats, Raimon M.
  • Tsapakis, Manolis
  • Tysklind, Mats
  • van Drooge, Barend L.
  • Veal, Cameron J.
  • Wong, Charles S.
Persistent organic pollutants (POPs) are recognized as pollutants of global concern, but so far, information on the trends of legacy POPs in the waters of the world has been missing due to logistical, analytical, and financial reasons. Passive samplers have emerged as an attractive alternative to active water sampling methods as they accumulate POPs, represent time-weighted average concentrations, and can easily be shipped and deployed. As part of the AQUA-GAPS/MONET, passive samplers were deployed at 40 globally distributed sites between 2016 and 2020, for a total of 21 freshwater and 40 marine deployments. Results from silicone passive samplers showed α-hexachlorocyclohexane (HCH) and γ-HCH displaying the greatest concentrations in the northern latitudes/Arctic Ocean, in stark contrast to the more persistent penta (PeCB)- and hexachlorobenzene (HCB), which approached equilibrium across sampling sites. Geospatial patterns of polychlorinated biphenyl (PCB) aqueous concentrations closely matched original estimates of production and use, implying limited global transport. Positive correlations between log-transformed concentrations of Σ7PCB, ΣDDTs, Σendosulfan, and Σchlordane, but not ΣHCH, and the log of population density (p < 0.05) within 5 and 10 km of the sampling sites also supported limited transport from used sites. These results help to understand the extent of global distribution, and eventually time-trends, of organic pollutants in aquatic systems, such as across freshwaters and oceans. Future deployments will aim to establish time-trends at selected sites while adding to the geographical coverage., Authors thank the RECETOX Research Infrastructure (no. LM2018121) financed by the Ministry of Education, Youth and Sports, and the Operational Programme Research, Development and Education (the CETOCOEN Excellence project no. CZ.02.1.01/0.0/0.0/17_043/0009632) for supportive background. This work was supported by the European Union’s Horizon 2020 research and innovation program under grant agreement no. 857560. This publication reflects only the author’s view, and the European Commission is not responsible for any use that may be made of the information it contains. The results of the project were created with the financial support of the provider Czech Science Foundation within the project ’Holistic exposure and effect potential assessment of complex chemical mixtures in the aquatic environment’ no. 20-04676X. G., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Occurrence and diffusive air-seawater exchanges of organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCBs) in Fildes Bay, King George Island, Antarctica

  • Luarte, Thais
  • Hirmas-Olivares, Andrea
  • Höfer, Juan
  • Giesecke, Ricardo
  • Mestre, Mireia
  • Guajardo-Leiva, Sergio
  • Castro-Nallar, Eduardo
  • Pérez-Parada, Andrés
  • Chiang, Gustavo
  • Lohmann, Rainer
  • Dachs, Jordi
  • Nash, Susan Bengtson
  • Pulgar, José
  • Pozo, Karla
  • Přibylová, Petra P.
  • Martiník, Jakub
  • Galbán-Malagón, Cristóbal
We report the levels of organochlorine pesticides (OCPs) and polychlorinated biphenyls (PCBs) in seawater and air, and the air-sea dynamics through diffusive exchange analysis in Fildes Bay, King George Island, Antarctica, between November 2019 and January 30, 2020. Hexachlorobenzene (HCB) was the most abundant compound in both air and seawater with concentrations around 39 ± 2.1 pg m-3 and 3.2 ± 2.4 pg L-1 respectively. The most abundant PCB congener was PCB 11, with a mean of 3.16 ± 3.7 pg m-3 in air and 2.0 ± 1.1 pg L-1 in seawater. The fugacity gradient estimated for the OCP compounds indicate a predominance of net atmospheric deposition for HCB, α-HCH, γ-HCH, 4,4'-DDT, 4,4'-DDE and close to equilibrium for the PeCB compound. The observed deposition of some OCs may be driven by high biodegradation rates and/or settling fluxes decreasing the concentration of these compounds in surface waters, which is supported by the capacity of microbial consortium to degrade some of these compounds. The estimated fugacity gradients for PCBs showed differences between congeners, with net volatilization predominating for PCB-9, a trend close to equilibrium for PCB congeners 11, 28, 52, 101, 118, 138, and 153, and deposition for PCB 180. Snow amplification may play an important role for less hydrophobic PCBs, with volatilization predominating after snow/glacier melting. As hydrophobicity increases, the biological pump decreases the concentration of PCBs in seawater, reversing the fugacity gradient to atmospheric deposition. This study highlights the potential impacts of climate change, through glacier retreat, on the biogeochemistry of POPs, remobilizing those compounds previously trapped within the cryosphere which in turn will transform the Antarctic cryosphere into a secondary source of the more volatile POPs in coastal areas, influenced by snow and ice melting., This study was funded by ANID/FONDECYT/Regular 1161504 (KP), ANID/FONDECYT/Regular 1210946 (CGM), ANID-PIA-INACH-ACT192057 (CGM, ECN), INACH REGULAR RT_12_17 (CGM), INACH DG_02_21 (TL), INACH MG_09_22 (AH), INACH RT_32_22 (GC), INACH RG_49_19 (MM), ANID/FONDECYT/REGULAR 12111338 (JH) and 1200834 (ECN), ANID FONDECYT POSTDOC 3210547 (SG), COPAS COASTAL ANID FB210021 (MM), FONDAP IDEAL 1515003 (JH, RG, MM), Spanish Ministry of Science and Innovation MCIN/AEI/10.13039/501100011033 (MM) Ramón y Cajal Fellowship (RYC2021-031946-I), European Union «NextGenerationEU»/PRTR (MM). The authors acknowledge the support of the Research Infrastructures RECETOX RI (No LM2018121, LM2023069) and the project CETOCOEN EXCELLENCE (No. CZ.02.1.01/0.0/0.0/17_043/0009632) funded by the Ministry of Education, Youth and Sports of the Czech Republic. This work was supported from the European Union's Horizon 2020 - Research and Innovation Framework Programme under grant agreement No 857560 (PP, JM, KP)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Innovative analytical methodologies for characterizing chemical exposure with a view to next-generation risk assessment

  • Tkalec, Žiga
  • Antignac, Jean-Philippe
  • Bandow, Nicole
  • Béen, Frederic M.
  • Belova, Lidia
  • Bessems, Jos
  • Le Bizec, Bruno
  • Brack, Werner
  • Cano-Sancho, German
  • Chaker, Jade
  • Covaci, Adrian
  • Creusot, Nicolas
  • David, Arthur
  • Debrauwer, Laurent
  • Dervilly, Gaud
  • Duca, Radu Corneliu
  • Fessard, Valérie
  • Grimalt, Joan O.
  • Guerin, Thierry
  • Habchi, Baninia
  • Hecht, Helge
  • Hollender, Juliane
  • Jamin, Emilien L.
  • Klánová, Jana
  • Kosjek, Tina
  • Krauss, Martin
  • Lamoree, Marja
  • Lavison-Bompard, Gwenaelle
  • Meijer, Jeroen
  • Moeller, Ruth
  • Mol, Hans
  • Mompelat, Sophie
  • Van Nieuwenhuyse, An
  • Oberacher, Herbert
  • Parinet, Julien
  • Van Poucke, Christof
  • Roškar, Robert
  • Togola, Anne
  • Trontelj, Jurij
  • Price, Elliott J.
The chemical burden on the environment and human population is increasing. Consequently, regulatory risk assessment must keep pace to manage, reduce, and prevent adverse impacts on human and environmental health associated with hazardous chemicals. Surveillance of chemicals of known, emerging, or potential future concern, entering the environment-food-human continuum is needed to document the reality of risks posed by chemicals on ecosystem and human health from a one health perspective, feed into early warning systems and support public policies for exposure mitigation provisions and safe and sustainable by design strategies. The use of less-conventional sampling strategies and integration of full-scan, high-resolution mass spectrometry and effect-directed analysis in environmental and human monitoring programmes have the potential to enhance the screening and identification of a wider range of chemicals of known, emerging or potential future concern. Here, we outline the key needs and recommendations identified within the European Partnership for Assessment of Risks from Chemicals (PARC) project for leveraging these innovative methodologies to support the development of next-generation chemical risk assessment., This project was co-funded from the Horizon Europe programme under grant agreement 101057014 (PARC). ŽT, HH, JK and EJP acknowledge the research infrastructure RECETOX RI (LM2023069), the support from European Union’s Horizon 2020 research and innovation program under grant agreement No 857560 (CETOCOEN Excellence) and OP RDE (CZ.02.1.01/0.0/0.0/17_043/0009632) and CETOCOEN PLUS (CZ.02.1.01/0.0/0.0/15_003/0000469). LB acknowledges funding through Research Foundation Flanders (FWO) fellowship (11G1821N). AC acknowledges the FWO research infrastructure EIRENE-Flanders (FWO I001923N) and the Exposome Centre of Excellence of the University of Antwerp (BOF grant, Antigoon database number 41222). The authors kindly thank Karl Lilja, Anja Duffek, Christophe Rousselle and Lutz Ahrens for their comments and suggestions during manuscript preparation. Views and opinions expressed are those of the author(s) only and do not necessarily reflect those of the European Union or the granting authority, European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for any use that may be made of the information it contains., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Making waves: The NORMAN antibiotic resistant bacteria and resistance genes database (NORMAN ARB&ARG)-An invitation for collaboration to tackle antibiotic resistance

  • Alygizakis, Nikiforos
  • Ng, Kelsey
  • Čirka, Ľuboš
  • Berendonk, Thomas
  • Cerqueira, Francisco
  • Cytryn, Eddie
  • Deviller, Geneviève
  • Fortunato, Gianuario
  • Iakovides, Iakovos C.
  • Kampouris, Ioannis
  • Michael-Kordatou, Irene
  • Lai, Foon Yin
  • Lundy, Lian
  • Manaia, Celia M.
  • Marano, Roberto B. M.
  • Paulus, Gabriela K.
  • Piña, Benjamín
  • Radu, Elena
  • Rizzo, Luigi
  • Ślipko, Katarzyna
  • Kreuzinger, Norbert
  • Thomaidis, Nikolaos S.
  • Ugolini, Valentina
  • Vaz-Moreira, Ivone
  • Slobodnik, Jaroslav
  • Fatta-Kassinos, Despo
With the global concerns on antibiotic resistance (AR) as a public health issue, it is pivotal to have data exchange platforms for studies on antibiotic resistant bacteria (ARB) and antibiotic resistance genes (ARGs) in the environment. For this purpose, the NORMAN Association is hosting the NORMAN ARB&ARG database, which was developed within the European project ANSWER. The present article provides an overview on the database functionalities, the extraction and the contribution of data to the database. In this study, AR data from three studies from China and Nepal were extracted and imported into the NORMAN ARB&ARG in addition to the existing AR data from 11 studies (mainly European studies) on the database. This feasibility study demonstrates how the scientific community can share their data on AR to generate an international evidence base to inform AR mitigation strategies. The open and FAIR data are of high potential relevance for regulatory applications, including the development of emission limit values / environmental quality standards in relation to AR. The growth in sharing of data and analytical methods will foster collaboration on risk management of AR worldwide, and facilitate the harmonization in the effort for identification and surveillance of critical hotspots of AR. The NORMAN ARB&ARG database is publicly available at: https://www.norman-network.com/nds/bacteria/., Authors gratefully acknowledge the International Commission for the Protection of Danube River (ICPDR) for the guidance and support. We are thankful to the researchers who participated in the Joint Danube Survey 4. One of the authors, Kelsey Ng, thanks the RECETOX Research Infrastructure (No. LM2023069) financed by the Ministry of Education, Youth and Sports fur supportive background. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No. 859891 and was supported from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 857560. This publication reflects only the authors’ view and the European Commission is not responsible for any use that may be made of the information it contains. Foon Yin Lai acknowledges the funding from FORMAS (project number: 2019-01161) and her SLU Career Grant., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Comprehensive characterization of European house dust contaminants: Concentrations and profiles, geographical variability, and implications for chemical regulation and health risk

  • Haglund, Peter
  • Alygizakis, Nikiforos A.
  • Covaci, Adrian
  • Melymuk, Lisa
  • Nizzetto, Pernilla Bohlin
  • Rostkowski, Pawel
  • Albinet, Alexandre
  • Alirai, Sylvana
  • Aurich, Dagny
  • Bieber, Stefan
  • Ballesteros-Gómez, Ana
  • Brennan, Amanda A.
  • Budzinski, Hélène
  • Castro, Gabriela
  • den Ouden, Fatima
  • Dévier, Marie-Hélène
  • Dulio, Valeria
  • Feng, Yong-Lai
  • Gabriel, Marta
  • Gallampois, Christine
  • García-Vara, Manuel
  • Giovanoulis, Georgios
  • Harrad, Stuart
  • Jacobs, Griet
  • Jobst, Karl J.
  • Kaserzon, Sarit
  • Kumirska, Jolanta
  • Lestremau, Francois
  • Lambropoulou, Dimitra
  • Letzel, Thomas
  • López de Alda, Miren
  • Nipen, Maja
  • Oswald, Peter
  • Poma, Giulia
  • Přibylová, Petra
  • Price, Elliott J.
  • Raffy, Gaëlle
  • Schulze, Bastian
  • Schymanski, Emma L.
  • Šenk, Petr
  • Wei, Si
  • Slobodnik, Jaroslav
  • Andújar, Begoña Talavera
  • Täubel, Martin
  • Thomaidis, Nikolaos S.
  • Wang, Thanh
  • Wang, Xianyu
This study investigated the concentration profiles and geographical variability of contaminants in house dust across Europe. A collaborative trial (CT) was organized by the NORMAN network using pooled dust and advanced chromatographic and mass spectrometric techniques combined with suspect screening and non-target screening (NTS). Over 1200 anthropogenic compounds were tentatively identified. Additionally, seventy-five individual samples were subjected to target analysis and NTS. The median concentrations of most contaminants varied <3-fold across Europe, and the contaminant profile of European dust was similar to that of North American dust, which was investigated in a previous CT. This similarity may be attributed to the use of similar consumer articles and building materials throughout the developed world. Multivariate data analysis revealed geographical trends in contaminant distribution, with north-south gradients across Europe. Geographical trends were more frequently found for compounds with rapid release (pharmaceuticals, personal care products, fragrances, pesticides, biocides) and smoke-related compounds. The concentrations of chlorinated paraffins, polycyclic aromatic hydrocarbons (PAHs), perfluorinated alkyl substances and stimulants generally increased from north to south, whereas the biocides levels decreased from north to south. Despite widespread presence of in-use contaminants in dusts, some of the highest risks come from compounds that have been restricted for decades or more. These include di(2-ethylhexyl) phthalate (DEHP), polychlorinated biphenyl (PCB) 118 and polybrominated diphenyl ethers 47, 99, and 153. DEHP remains the most abundant contaminant in European house dust, while the other compounds are classified as persistent organic pollutants (POPs). Moreover, there is a striking lack of reliable toxicity data, particularly for emerging compounds. For instance, although acceptable daily intakes (ADIs) were examined for 202 compounds, only 46 had consensus-based ADI values. The results highlight the need for proactive measures to prevent hazardous chemicals from entering the market and for careful selection of substitute chemicals, when such are needed, to avoid regrettable substitutions., The NORMAN Association Working Group 6 on Indoor Environments and Ambient Air and Cross Working Group on NTS are acknowledged for initiating the collaborative trial and geographic distribution study. The work at the University of Antwerp was financially supported by the Interuniversity Special Research Fund from Flanders (GISMO 01IB1320, Flexigut project), and the Exposome Centre of Excellence of the University of Antwerp (BOF grant, Antigoon database number 41222). The work at Masaryk University was supported by the Czech Science Foundation (GAČR), project No. 22-32743S and the RECETOX Research Infrastructure (No LM2023069) financed by the Ministry of Education, Youth and Sports, and the European Union’s Horizon 2020 research and innovation program under grant agreement No 857560. Michal Novakowski, Adam Mickiewicz University, Poznań, Poland is acknowledged for assistance with sampling. BTA, DA & ELS acknowledge Randolph Singh and NTNU acknowledge Alexandros G. Asimakopoulos and Dr. Susana V. Gonzalez for technical assistance in the analysis of their samples. BTA acknowledges funding from the “Microbiomes in One Health” PhD training program, supported by the PRIDE doctoral research funding scheme (PRIDE/11823097) of the Luxembourg National Research Fund (FNR). ELS, DA acknowledge funding support from the FNR for project A18/BM/12341006. DA acknowledges funding from the University of Luxembourg Institute for Advanced Studies (IAS) for the Audacity project “LuxTIME”. The work at University of Bordeaux (UB) was supported by the PLATINE Infrastructure, financed by the “Région Nouvelle Aquitaine” and the French Research Ministry (CPER A2E), by the French National Agency (TRANSPRO project; ANR-18-CE04-0006), and by the Nouvelle Aquitaine Region (ETRAC project). UB acknowledge C. Gardia-Parege and E. Geneste for technical assistance in the analysis of their samples. TW acknowledges the funding from FORMAS (2020-01163). The work at IDAEA-CSIC was supported by the by the grant CEX2018–000794-S funded by MCIN/AEI (10.13039/501100011033) and by the Government of Catalonia (2021 SGR 00753). AA, FL and VD acknowledges funding from the French Ministry of Environment. The views expressed in this article are those of the authors and do not necessarily represent the views or policies of the U.S. Environmental Protection Agency. This publication reflects only the authors’ view, and the European Commission is not responsible for any use that may be made of the information it contains., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Datos de investigación Set de datos (Dataset)

[Dataset] Comprehensive characterization of European house dust contaminants: Concentrations and profiles, geographical variability, and implications for chemical regulation and health risk

  • Haglund, Peter
  • Alygizakis, Nikiforos A.
  • Covaci, Adrian
  • Melymuk, Lisa
  • Nizzetto, Pernilla Bohlin
  • Rostkowski, Pawel
  • Albinet, Alexandre
  • Alirai, Sylvana
  • Aurich, Dagny
  • Bieber, Stefan
  • Ballesteros-Gómez, Ana
  • Brennan, Amanda A.
  • Budzinski, Hélène
  • Castro, Gabriela
  • den Ouden, Fatima
  • Dévier, Marie-Hélène
  • Dulio, Valeria
  • Feng, Yong-Lai
  • Gabriel, Marta
  • Gallampois, Christine
  • García-Vara, Manuel
  • Giovanoulis, Georgios
  • Harrad, Stuart
  • Jacobs, Griet
  • Jobst, Karl J.
  • Kaserzon, Sarit
  • Kumirska, Jolanta
  • Lestremau, Francois
  • Lambropoulou, Dimitra
  • Letzel, Thomas
  • de Alda, Miren López
  • Nipen, Maja
  • Oswald, Peter
  • Poma, Giulia
  • Přibylová, Petra
  • Price, Elliott J.
  • Raffy, Gaëlle
  • Schulze, Bastian
  • Schymanski, Emma L.
  • Šenk, Petr
  • Wei, Si
  • Slobodnik, Jaroslav
  • Andújar, Begoña Talavera
  • Täubel, Martin
  • Thomaidis, Nikolaos S.
  • Wang, Thanh
  • Wang, Xianyu
This study investigated the concentration profiles and geographical variability of contaminants in house dust across Europe. A collaborative trial (CT) was organized by the NORMAN network using pooled dust and advanced chromatographic and mass spectrometric techniques combined with suspect screening and non-target screening (NTS). Over 1200 anthropogenic compounds were tentatively identified. Additionally, seventy-five individual samples were subjected to target analysis and NTS. The median concentrations of most contaminants varied <3-fold across Europe, and the contaminant profile of European dust was similar to that of North American dust, which was investigated in a previous CT. This similarity may be attributed to the use of similar consumer articles and building materials throughout the developed world. Multivariate data analysis revealed geographical trends in contaminant distribution, with north-south gradients across Europe. Geographical trends were more frequently found for compounds with rapid release (pharmaceuticals, personal care products, fragrances, pesticides, biocides) and smoke-related compounds. The concentrations of chlorinated paraffins, polycyclic aromatic hydrocarbons (PAHs), perfluorinated alkyl substances and stimulants generally increased from north to south, whereas the biocides levels decreased from north to south. Despite widespread presence of in-use contaminants in dusts, some of the highest risks come from compounds that have been restricted for decades or more. These include di(2-ethylhexyl) phthalate (DEHP), polychlorinated biphenyl (PCB) 118 and polybrominated diphenyl ethers 47, 99, and 153. DEHP remains the most abundant contaminant in European house dust, while the other compounds are classified as persistent organic pollutants (POPs). Moreover, there is a striking lack of reliable toxicity data, particularly for emerging compounds. For instance, although acceptable daily intakes (ADIs) were examined for 202 compounds, only 46 had consensus-based ADI values. The results highlight the need for proactive measures to prevent hazardous chemicals from entering the market and for careful selection of substitute chemicals, when such are needed, to avoid regrettable substitutions., The NORMAN Association Working Group 6 on Indoor Environments and Ambient Air and Cross Working Group on NTS are acknowledged for initiating the collaborative trial and geographic distribution study. The work at the University of Antwerp was financially supported by the Interuniversity Special Research Fund from Flanders (GISMO 01IB1320, Flexigut project), and the Exposome Centre of Excellence of the University of Antwerp (BOF grant, Antigoon database number 41222). The work at Masaryk University was supported by the Czech Science Foundation (GAČR), project No. 22-32743S and the RECETOX Research Infrastructure (No LM2023069) financed by the Ministry of Education, Youth and Sports, and the European Union’s Horizon 2020 research and innovation program under grant agreement No 857560. Michal Novakowski, Adam Mickiewicz University, Poznań, Poland is acknowledged for assistance with sampling. BTA, DA & ELS acknowledge Randolph Singh and NTNU acknowledge Alexandros G. Asimakopoulos and Dr. Susana V. Gonzalez for technical assistance in the analysis of their samples. BTA acknowledges funding from the “Microbiomes in One Health” PhD training program, supported by the PRIDE doctoral research funding scheme (PRIDE/11823097) of the Luxembourg National Research Fund (FNR). ELS, DA acknowledge funding support from the FNR for project A18/BM/12341006. DA acknowledges funding from the University of Luxembourg Institute for Advanced Studies (IAS) for the Audacity project “LuxTIME”. The work at University of Bordeaux (UB) was supported by the PLATINE Infrastructure, financed by the “Région Nouvelle Aquitaine” and the French Research Ministry (CPER A2E), by the French National Agency (TRANSPRO project; ANR-18-CE04-0006), and by the Nouvelle Aquitaine Region (ETRAC project). UB acknowledge C. Gardia-Parege and E. Geneste for technical assistance in the analysis of their samples. TW acknowledges the funding from FORMAS (2020-01163). The work at IDAEA-CSIC was supported by the by the grant CEX2018–000794-S funded by MCIN/AEI (10.13039/501100011033) and by the Government of Catalonia (2021 SGR 00753). AA, FL and VD acknowledges funding from the French Ministry of Environment. The views expressed in this article are those of the authors and do not necessarily represent the views or policies of the U.S. Environmental Protection Agency. This publication reflects only the authors’ view, and the European Commission is not responsible for any use that may be made of the information it contains., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Spatial and Temporal Trends of Dissolved Polybrominated Diphenyl Ethers and Non-BDE Flame Retardants in the Aquatic Environment across Countries

  • Bao, Lian-Jun
  • Vrana, Branislav
  • Lohmann, Rainer
  • Sobotka, Jaromír
  • Smedes, Foppe
  • Muir, Derek
  • Allan, Ian J.
  • Astrahan, Peleg
  • Bidleman, Terry
  • Crowley, Denis
  • Dykyi, Evgen
  • Estoppey, Nicolas
  • Fillmann, Gilberto
  • Jantunen, Liisa
  • Kaserzon, Sarit
  • Maruya, Keith A.
  • McHugh, Brendan
  • Newman, Brent
  • Prats, Raimon M.
  • Tsapakis, Manolis
  • Sutton, Rebecca
  • Tysklind, Mats
  • van Drooge, Barend L.
  • Wong, Charles S.
  • Zeng, Eddy Y.
Measuring dissolved concentrations of polybrominated diphenyl ethers (PBDEs) and non-BDE flame retardants on a global scale provides critical insights into the effectiveness of the Stockholm Convention. In the present study, we deployed passive sampling devices at 43 seawater and freshwater sites covering 21 countries from 2016 to 2020. The detection frequencies were 20-94% for BDE congeners and 33-42% for dechlorane plus, higher than those (0-20%) for other target compounds. The median concentrations of dissolved Σ9PBDE (sum of BDE-28, -47, -66, -85, -99, -100, -153, -154, and -183) were 0.28 and 0.64 pg L-1 in seawater and freshwater, respectively. The concentrations of dissolved Σ9PBDE, along with published data, slightly increased before 2016 and remained steady from 2016 to 2018, indicating delayed effects of the global phaseout of technical Penta- and Octa-BDEs. The log-transformed concentrations of individual BDE congeners were better correlated with regional gross domestic product than with population density. The potential ecological risk of BDE-47 was low, and there was a lack of key risk indicators for other compounds. The present study documented the delayed response of the aquatic environment to the regulatory actions on reducing PBDE emissions., The authors thank the financial support from the National Natural Science Foundation of China (Nos. 42277198 and 21637001) and the Czech Science Foundation Grant No. 20-04676X. The authors also thank the RECETOX Research Infrastructure (No. LM2023069), financed by the Ministry of Education, Youth and Sport for supportive background. The authors are grateful to the deployment teams for their efforts, which are listed in the Supporting Information of the previous study. (12) This work was supported by the European Union’s Horizon 2020 research and innovation program under grant agreement No. 857560 (CETOCOEN Excellence). This publication reflects only the authors’ views, and the European Commission is not responsible for any use that may be made of the information it contains., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Advancing tools for human early lifecourse exposome research and translation (ATHLETE): Project overview

  • Vrijheid, Martine
  • Basagaña Flores, Xavier
  • González, Juan Ramón
  • Porcel, Joana
  • Bustamante Pineda, Mariona
  • Casas Sanahuja, Maribel
  • Dadvand, Payam
  • Fossati, Serena
  • Guxens Junyent, Mònica
  • Maitre, Léa
  • Nieuwenhuijsen, Mark
  • Ortiz, Rodney
  • Stratakis, Nikos
  • Sunyer Deu, Jordi
  • Slama, Rémy
Early life stages are vulnerable to environmental hazards and present important windows of opportunity for lifelong disease prevention. This makes early life a relevant starting point for exposome studies. The Advancing Tools for Human Early Lifecourse Exposome Research and Translation (ATHLETE) project aims to develop a toolbox of exposome tools and a Europe-wide exposome cohort that will be used to systematically quantify the effects of a wide range of community- and individual-level environmental risk factors on mental, cardiometabolic, and respiratory health outcomes and associated biological pathways, longitudinally from early pregnancy through to adolescence. Exposome tool and data development include as follows: (1) a findable, accessible, interoperable, reusable (FAIR) data infrastructure for early life exposome cohort data, including 16 prospective birth cohorts in 11 European countries; (2) targeted and nontargeted approaches to measure a wide range of environmental exposures (urban, chemical, physical, behavioral, social); (3) advanced statistical and toxicological strategies to analyze complex multidimensional exposome data; (4) estimation of associations between the exposome and early organ development, health trajectories, and biological (metagenomic, metabolomic, epigenetic, aging, and stress) pathways; (5) intervention strategies to improve early life urban and chemical exposomes, co-produced with local communities; and (6) child health impacts and associated costs related to the exposome. Data, tools, and results will be assembled in an openly accessible toolbox, which will provide great opportunities for researchers, policymakers, and other stakeholders, beyond the duration of the project. ATHLETE's results will help to better understand and prevent health damage from environmental exposures and their mixtures from the earliest parts of the life course onward., ISGlobal acknowledges support from the Spanish Ministry of Science, Innovation and Universities through the “Centro de Excelencia Severo Ochoa 2019–2023” Program (CEX2018-000806-S) and support from the Generalitat de Catalunya through the Centres de Recerca de Catalunya Program. We acknowledge collaboration with European projects, specifically: Human Early Life Exposome (HELIX) (FP7 grant agreement number 308333), LifeCycle (H2020 grant agreement number 733206), and Connecting Europe and Canada in personalized health (EUCAN-Connect) (H2020 Grant Agreement number 824989). The Born in Bradford (BiB) cohort is only possible because of the enthusiasm and commitment of the Children and Parents in BiB. We are grateful to all the participants, health professionals, and researchers who have made BiB happen. The BiB cohort is only possible because of the enthusiasm and commitment of the children and parents in BiB. We are grateful to all the participants, health professionals, schools, and researchers who have made BiB happen. BiB has received funding from the Wellcome Trust (101597), a joint grant from the UK Medical Research Council and UK Economic and Social Science Research Council (MR/N024391/1), a British Heart Foundation Clinical Study grant (CS/16/4/32482). The Norwegian Mother, Father and Child Cohort Study is supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research. We are grateful to all the participating families in Norway who take part in this ongoing cohort study. The Danish National Birth Cohort was established with a significant grant from the Danish National Research Foundation. Additional support was obtained from the Danish Regional Committees, the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Health Foundation, and other minor grants. The Danish National Birth Cohort Biobank has been supported by the Novo Nordisk Foundation and the Lundbeck Foundation. Follow-up of mothers and children have been supported by the Danish Medical Research Council (SSVF 0646, 271-08-0839/06-066023, O602-01042B, 0602-02738B); the Lundbeck Foundation (195/04, R100-A9193); The Innovation Fund Denmark 0603-00294B (09-067124); the Nordea Foundation (02-2013-2014); Aarhus Ideas (AU R9-A959-13-S804); University of Copenhagen Strategic Grant (IFSV 2012); and the Danish Council for Independent Research (DFF—4183-00594 and DFF—4183-00152). The general design of the Generation R Study is made possible by financial support from the Erasmus MC, University Medical Center, Rotterdam, Erasmus University Rotterdam, Netherlands Organization for Health Research and Development (ZonMw), Netherlands Organisation for Scientific Research (NWO), Ministry of Health, Welfare and Sport, and Ministry of Youth and Families. This project received funding from the European Union’s Horizon 2020 research and innovation programme (LIFECYCLE, grant agreement number 733206, 2016; EUCAN-Connect grant agreement number 824989; ATHLETE, grant agreement number 874583). We gratefully acknowledge the contribution of participants, research collaborators, general practitioners, hospitals, midwives, and pharmacies in Rotterdam. The INfancia y Medio Ambiente cohort (INMA) Sababell study was funded by grants from Instituto de Salud Carlos III (Red INMA G03/176; CB06/02/0041; PI041436; PI081151 incl. Fondo Europeo de Desarollo Regional (FEDER) funds; PI12/01890 incl. FEDER funds; CP13/00054 incl. FEDER funds; PI15/00118 incl. FEDER funds; CP16/00128 incl. FEDER funds; PI16/00118 incl. FEDER funds; PI16/00261 incl. FEDER funds; PI17/01340 incl. FEDER funds, PI18/00547 incl. FEDER funds, PI20/01695 incl. FEDER funds), Centro de Investigación Biomédica en Red - Epidemiología y Salud Pública (CIBERESP), Generalitat de Catalunya-Comissió Interdepartamental de Recerca i Innovació Tecnològia 1999SGR 00241, Generalitat de Catalunya-Agencia de Gestión de Ayudas Universitarias y de Investigación (2009 SGR 501, 2014 SGR 822), Fundació La Marató de TV3 (090430), Spanish Ministry of Economy and Competitiveness (SAF2012-32991 incl. FEDER funds), Agence Nationale de Securite Sanitaire de l’Alimentation de l’Environnement et du Travail (1262C0010; EST-2016 RF-21, EST-19 RF-04), and the European Commission (261357, 308333, 603794 and 634453). The INMA Valencia study was supported by grants from Instituto de Salud Carlos III (FIS-FEDER: 13/2032, 13/1944, 14/00891, 16/1288, 17/00663, and 19/1338; Miguel Servet-FSE: CP15/0025 and MSII16/00051, 00051, and MSII20/0006), Alicia Koplowitz Foundation 2017, Generalitat Valenciana (AICO/2020/285), and Spanish Association Against Cancer (AECC) “Seed Ideas” 2019 (IDEAS19098LOPE). INMA Gipuzkoa was funded by grants from Instituto de Salud Carlos III (FIS-PI06/0867, FIS-PI09/00090, FIS-PI13/02187, and FIS-PI18/01142 incl. FEDER funds), CIBERESP, Department of Health of the Basque Government (2005111093, 2009111069, 2013111089, and 2015111065), and the Provincial Government of Gipuzkoa (DFG06/002, DFG08/001, and DFG15/221) and annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain). The Sepages cohort would like to thank the Grenoble University Hospital (CHU-GA) biobank (bb-0033-00069). We thank the Sepages Study group (E. Eyriey, P. Hoffmann, E. Hullo, J. Lepeule, C. Llerena, S. Lyon-Caen, X. Morin, A. Morlot, C. Philippat, I. Pin, J. Quentin, V. Siroux, R. Slama) and the participants of the Suivi de l’Exposition à la Pollution Atmosphérique durant la Grossesse et Effets sur la Santé (SEPAGES) study. We acknowledge support from Auvergne-Rhône-Alpes Région, Soutien aux coopérations universitaires et scientifiques internationales fund to support collaborations between Catalunya and Auvergne-Rhône-Alpes. SEPAGES cohort was supported by the European Research Council (consolidator grant N 311765-E-DOHaD, Principal Investigator [PI], R. Slama), by French National Research Agency (ANR), the ANR (Pregnancy, Air Pollution, Epigenetics and Respiratory health project ANR-12-PDOC-0029-01, PI, J. Lepeule; A Longitudinal Analysis of Effects of Early Life Exposure to Phenols on Health in Humans project, 14-CE21-0007-01, PI, R. Slama; Gut Microbiota in early childhood and Maternal Environmental exposures project, PI, R. Slama; Prenatal Exposure to Tobacco smoking and Air Pollution and Effects on offspring respiratory and neurodevelopmental outcomes ANR 18-CE36-005, PI, J. Lepeule). The Central European Longitudinal Study of Pregnacy and Childhood: The Next Generation (TNG) cohort is supported by the RECETOX research infrastructure (the Ministry of Education, Youth and Sports of the Czech Republic: LM2018121) and the CETOCOEN EXCELLENCE Teaming 2 project of European Union (EU) Horizon 2020 (857560) and the MEYS of the Czech Republic (02.1.01/0.0/0.0/18_ 046/0015975). The Barcelona Life Study Cohort has received funding from European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme under grant agreement number (785994) (Prenatal exposure to urban air pollution and pre and post-natal brain development project) and from the Health Effects Institute (HEI) under Agreement number 4959-RFPA15-1/18-1 (FRONTIER project). Genotyping in the HELIX study was supported by project PI17/01225 (Instituto de Salud Carlos III, co-funded by European Union [European Regional Development Fund], “A way to make Europe”) and the Centro Nacional de Genotipado-CEGEN (PRB2-ISCIII). The Nascita e Infanzia: gli Effetti dell’Ambiente cohort was partially funded by the Compagnia SanPaolo Foundation and the Piedmont Region. The Piccolipiù project was funded by the Italian National Center for Disease Prevention and Control (National Centre for Disease Prevention and Control grants years 2010 and 2014) and by the Italian Ministry of Health (art 12 and 12 bis D.lgs 502/92). The Perturbateurs Endocriniens: Étude Longitudinale sur les Anomalies de la Grossesse, l’Infertilité et l’Enfance study is supported by National Institute of Health and Medical Research and has received multiple funds from the ANR, the French Agency for Food, Environmental and Occupational Health and Safety (ANSES), the Fondation de France, the National Institute for Public Health Surveillance (InVS), the French, Ministry of Labor, the French Ministry of Health, and the French Ministry of Ecology. DataSHIELD is funded under a group of projects that underpin a program of development and application of secure methods for co-analysis, data sharing, and visualization in the Population Health Sciences Institute at Newcastle University (United Kingdom). These include: the “Connected Health Cities project” (North East and North Cumbria) funded by the UK Department of Health (RES/0150/7943/202); the “EUCanConnect project” (European Commission H2020 Flagship Collaboration with Canada); the “58FORWARDS project” (Fostering new Opportunities for Researchers via Wider Access to Research Data and Samples) funded jointly by the Wellcome Trust and the Medical Research Council (108439/Z/15/Z); and the “METADAC project” (Managing Ethico-social, Technical and Administrative issues in Data ACcess) funded jointly by the Medical Research Council, the Wellcome Trust, and the Economic and Social Research Council (MR/N01104X/1 and MR/N01104X/2). We acknowledge the Molecular Genetics Information System team, including Fleur Kelpin, Tommy de Boer, Mariska Slofstra, Connor Stroomberg, Jelmer Veen, Jeroen van Veen, Fernanda de Andrade, Marije van der Geest, Dieuwke Roelofs-Prins, Dennis Hendriksen, Bart Charbon, Joeri van der Velde, Max Postema, Erik Schaberg, Christiaan Hilbrands, Alexander Kellmann, and Luuk Dijkhuis.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

External exposome and incident asthma across the life course in 14 European cohorts: a prospective analysis within the EXPANSE project

  • Yu, Zhebin
  • Dadvand, Payam
  • Tonne, Cathryn
  • EXPANSE Project Team
Background: The joint impact of exposure to multiple urban environmental factors on asthma remains unclear. Methods: We analysed data from 14 European cohorts to assess the impact of the urban exposome on asthma incidence across the life course. We linked three external exposome domains (air pollution, built environment, ambient temperature) to the participants’ home addresses at baseline. We performed k-means clustering within each domain and assessed associations of clusters with asthma adjusting for potentially relevant covariates in cohort-specific analyses, with subsequent separate meta-analyses for birth and adult cohorts. An environmental risk score using a coefficient-weighted sum approach was used to assess the impact of combining the three domains. Findings: A total of 7428 incident asthma cases were identified among 349,037 participants (from birth up to age 70+). Overall, we observed higher risks of asthma for clusters characterized by high particulate matter and nitrogen dioxide exposure in adults (ORmeta = 1.13, 95%CI:1.01–1.25), and clusters characterized by high built-up area and low levels of greenness in both children and adults (ORmeta = 1.36, 95%CI: 1.14–1.64 for birth cohorts and ORmeta = 1.15, 95%CI: 1.03–1.28 for adult cohorts, respectively). The joint exposure using the environment risk score combining the three domains was consistently associated with higher risks of incident asthma (ORmeta = 1.13, 95%CI: 1.07–1.20 for birth cohorts, ORmeta = 1.15, 95%CI: 1.10–1.20 for adult cohorts per 20% increase). On average 11.6% of the incident asthma cases could be attributed to environmental risk score above cohort-specific median levels. Interpretation: Multiple environmental exposures jointly contribute to incident asthma risk across the life course. Urban planning accounting for these factors may help mitigate asthma development. Funding: This study was funded by the European Union’s Horizon 2020 research and innovation program under agreement No 874627 (EXPANSE)., This study was funded by the European Union’s Horizon 2020 research and innovation program under agreement No 874627 (EXPANSE) and No 857560 (CETOCOEN Excellence). ZY is funded by the Swedish Research Council (VR No. 2024-02345) and Swedish Research Council for Health, Working life and Welfare (Forte No. 2023-01213). AS has received funding from the Swiss National Science Foundation (grant number 210781). MS received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No. 949906). PD and CT acknowledge support from the grant CEX2023-0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. Cohort-specific fundings are presented in the Supplementary materials. Authors thank the RECETOX Research Infrastructure (No LM2023069) financed by the Ministry of Education, Youth and Sports for supportive background. EM reports grants from Swedish Research Council (2024-03164), The Swedish Heart-Lung Foundation and Region Stockholm (ALF).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Adopting mechanistic molecular biology approaches in exposome research for causal understanding

  • Foreman, Amy L.
  • Warth, Benedikt
  • Hessel, Ellen V. S.
  • Price, Elliott J.
  • Schymanski, Emma L.
  • Cantelli, Gaia
  • Parkinson, Helen
  • Hecht, Helge
  • Klánová, Jana
  • Vlaanderen, Jelle
  • Hilscherova, Klara
  • Vrijheid, Martine
  • Vineis, Paolo
  • Araujo, Rita
  • Barouki, Robert
  • Vermeulen, Roel
  • Lanone, Sophie
  • Brunak, Søren
  • Sebert, Sylvain
  • Karjalainen, Tuomo
Through investigating the combined impact of the environmental exposures experienced by an individual throughout their lifetime, exposome research provides opportunities to understand and mitigate negative health outcomes. While current exposome research is driven by epidemiological studies that identify associations between exposures and effects, new frameworks integrating more substantial population-level metadata, including electronic health and administrative records, will shed further light on characterizing environmental exposure risks. Molecular biology offers methods and concepts to study the biological and health impacts of exposomes in experimental and computational systems. Of particular importance is the growing use of omics readouts in epidemiological and clinical studies. This paper calls for the adoption of mechanistic molecular biology approaches in exposome research as an essential step in understanding the genotype and exposure interactions underlying human phenotypes. A series of recommendations are presented to make the necessary and appropriate steps to move from exposure association to causation, with a huge potential to inform precision medicine and population health. This includes establishing hypothesis-driven laboratory testing within the exposome field, supported by appropriate methods to read across from model systems research to human., The contents of this paper arose from a collaborative workshop run in 2020 on “Connecting molecular biology and big data in humans to study the exposome” funded and coordinated by the Human Ecosystems Transversal Theme (European Molecular Biology Laboratory) and Inserm with support provided by HP and GC. Thanks go to participants Ewan Birney, Remy Slama, Naomi Allen, Marc Chadeau, Andreas Kortenkamp, William Bourguet, Samuli Ripatti, Marc Chadeau-Hyam, and Xavier Basagańa. S.B. acknowledges support from the Novo Nordisk Foundation (grants NNF17OC0027594 and NNF14CC0001). E.L.S. acknowledges funding support from the Luxembourg National Research Fund (FNR) for project A18/BM/12341006. E.J.P., H.H., J.K., and K.H. acknowledge the research infrastructure RECETOX RI (LM2023069), H2020 CETOCOEN Excellence 857560, and OP RDE CZ.02.1.01/0.0/0.0/17_043/0009632. E.L.S. acknowledges funding support from the Luxembourg National Research Fund (FNR) for project A18/BM/12341006. This publication reflects only the authors’ views, and the European Commission is not responsible for any use that may be made of the information it contains.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Heat-related mortality in Europe during 2024 and health emergency forecasting to reduce preventable deaths

  • Janoš, Tomáš
  • Quijal-Zamorano, Marcos
  • Shartova, Natalia
  • Gallo, Elisa
  • Méndez Turrubiates, Raúl Fernando
  • Beltrán Barrón, Nadia Denisse
  • Peyrusse, Fabien
  • Ballester, Joan
Successive record-breaking summer temperatures, both globally and in Europe, raise the urgent question of how to better protect vulnerable populations. Here we quantified the heat-related mortality burden during the summers of 2022-2024, and assessed the forecast skill of a new generation of continental-wide, impact-based early warning systems during health emergencies. We fitted epidemiological models with the newly created, format-homogeneous daily mortality database of the EARLY-ADAPT project, covering 654 contiguous regions across 32 European countries, which represents the entire urban and rural population of 539 million people. We estimated 62,775 (95% confidence interval = 36,765-84,379) heat-related deaths in 2024, largely exceeding the burden in 2023 (50,798; 29,442-68,610), but somewhat smaller than that of 2022 (67,873; 38,465-92,455). We demonstrated that health emergencies can be forecast with high confidence at least 1 week in advance, even for highly vulnerable regions and population subgroups. These findings have implications for public health agencies and end users, given that the adoption of the system would enable reliable heat-health emergency alerts within the time window that is relevant for stakeholders to take effective actions to reduce preventable deaths., M.Q.-Z., N.S., E.G., R.F.M.T., N.D.B.B., F.P. and J.B. gratefully acknowledge funding from the European Union’s Horizon 2020 and Horizon Europe research and innovation programs (grant agreements 865564—European Research Council Consolidator Grant EARLY-ADAPT, https://www.early-adapt.eu/; 101069213—European Research Council Proof-of-Concept HHS-EWS, https://forecaster.health/ and 101123382—European Research Council Proof-of-Concept FORECAST-AIR). E.G. and J.B. additionally acknowledge funding from the European Union’s Horizon Europe research and innovation program (grant agreement 101057131—Horizon Europe project CATALYSE, https://catalysehorizon.eu/). ISGlobal authors acknowledge support from the grant CEX2018-000806-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. All authors acknowledge the use of ECMWF data from ERA5-Land and the Integrated Forecasting System. This work was supported by OP JAC—Project MSCAfellow7_MUNI (CZ.02.01.01/00/22_010/0008854) financed by the Ministry of Education, Youth and Sports—co-funded by the European Union. RECETOX authors thank the RECETOX Research Infrastructure (LM2023069), financed by the Ministry of Education, Youth and Sports, for its supportive background. This work was supported by the European Union’s Horizon 2020 research and innovation program (grant agreement 857560—CETOCOEN Excellence). This publication reflects only the author’s view, and the European Commission is not responsible for any use that may be made of the information it contains.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The 2026 Europe report of the Lancet Countdown on health and climate change: narrowing window for decisive health action

  • Kriit, Hedi K.
  • Chen-Xu, José
  • Achebak, Hicham
  • Alari, Anna
  • Alcayna, Tilly
  • Ball, Emily
  • Ballester, Joan
  • Cirach, Marta
  • Janoš, Tomáš
  • Nieuwenhuijsen, Mark J.
  • Shartova, Natalia
  • Stucki, Lara
  • Antó i Boqué, Josep Maria
  • Tonne, Cathryn
  • Rocklöv, Joacim
We thank the global Lancet Countdown and the Wellcome Trust (grant number 304972/Z/23/Z) for their financial and technical support. We acknowledge funding from the EU's Horizon Europe research and innovation programme under grant agreement numbers 101057131 (Horizon Europe project CATALYSE), 101057554 (Horizon Europe project IDAlert), 101057690 (Horizon Europe project CLIMOS), and UK Research and Innovation grant agreements numbers 10041512, 10038150, and 10039289. We thank the EU Climate Change and Health Cluster, which includes the CATALYSE, IDAlert, and CLIMOS grants. KRvD acknowledges a fellowship from the British Heart Foundation Cambridge Centre for Research Excellence (number RE/24/130011). TA acknowledges support from the Norwegian Red Cross and the Norwegian Ministry of Foreign Affairs. RH and MSo acknowledge funding from Research Council of Finland for Vegetation Fires and Smoke Pollution Warning and Advisory System for Europe (grant 359421) and the EU Horizon projects FirEUrisk (grant 101003890) and ClimAir (grant 101156799). JP acknowledges funding for EU Horizon project SYLVA (grant 101086109) and Research Council of Finland project SPORELIFE (grant 355851). GECC acknowledges joint centre funding from the UK Medical Research Council and the Department for International Development (grant MR/R0156600/1). GECC and DL were supported by the Barcelona Supercoming Center AI4Science Fellowship programme funded by the Recovery and Resilience Mechanism-Next Generation as part of the Spanish Ministry's Recovery, Transformation and Resilience Plan. TR, JCM, and MC acknowledge support from Wellcome Trust (PATHFINDER2, grant number 313586/Z/24/Z and DESTINY, grant number 227165/Z/23/Z) and gratefully acknowledge the Ministry of Research, Science and Culture of Land Brandenburg for supporting this project by providing resources on the high-performance computer system at the Potsdam Institute for Climate Impact Research (grant number 22-Z105-05/002/001). TJ gratefully acknowledges support from OP JAC - Project MSCAfellow7_MUNI (number CZ.02·01·01/00/22_010/0008854) financed by the Czech Republic's Ministry of Education, Youth and Sports and co-funded by the EU, support from the EU's Horizon 2020 research and innovation programme under grant agreement number 857560 (CETOCOEN Excellence), and the RECETOX Research Infrastructure (number LM2023069), financed by the Czech Republic's Ministry of Education, Youth and Sports, for supportive background. JB, HA, and NS gratefully acknowledge funding from the EU's Horizon 2020 and Horizon Europe research and innovation programmes under grant agreements 865564 (European Research Council Consolidator Grant EARLY-ADAPT), 101069213 (European Research Council Proof-of-Concept HHS-EWS), and 101123382 (European Research Council Proof-of-Concept FORECAST-AIR). ISGlobal authors JC-X, HA, AA, JB, MC, TJ, MNie, NS, LS, JMA, and CT acknowledge support from grant CEX2023–0001290-S funded by MCIN/AEI/10.13039/501100011033, and support from the Generalitat de Catalunya through the CERCA Program. JM-U and JT acknowledge the funding of the Ministerio de Ciencia e Innovación (Spain) grant number PID2024–159955NB-I00. RL acknowledges a Royal Society Dorothy Hodgkin Fellowship and the EU's Horizon Europe research and innovation programme (E4Warning, grant agreement 101086640, and IDAlert, grant agreement 101057554). We thank Herbert Kruitbosch, David Patterson, and Elmeri Niemi for their contribution to the production of the new litigation indicator. We thank Yasna Palmeiro Silva for the support provided for the adaptation indicators (2.1.1, 2.1.2, and 2.2.1). We thank Oliver Schmoll and Vladimir Kenodrowski, from WHO's Regional Office for Europe, for their continuous engagement with the Lancet Countdown Europe Report 2026. The views expressed here are those of the authors, and the European Commission is not responsible for any use that may be made of the information it contains.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Investigating exposure and hazards of micro- and nanoplastics during pregnancy and early life (AURORA Project): Protocol for an interdisciplinary study

  • Durkin, Amanda M.
  • Bustamante Pineda, Mariona
  • Dadvand, Payam
  • Vrijheid, Martine
  • Vermeulen, Roel
Background: Micro- and nanoplastics (MNPs) are emerging pollutants of concern with ubiquitous presence in global ecosystems. MNPs pose potential implications for human health; however, the health impacts of MNP exposures are not yet understood. Recent evidence suggests that MNPs can cross the placental barrier, underlying the urgent need to understand their impact on reproductive health and development. Objective: The Actionable eUropean ROadmap for early-life health Risk Assessment of micro- and nanoplastics (AURORA) project will investigate MNP exposures and their biological and health effects during pregnancy and early life, which are critical periods due to heightened vulnerability to environmental stressors. The AURORA project will enhance exposure assessment capabilities for measuring MNPs, MNP-associated chemicals, and plastic additives in human tissues, including placenta and blood. Methods: In this interdisciplinary project, we will advance methods for in-depth characterization and scalable chemical analytical strategies, enabling high-resolution and large-scale toxicological, exposure assessment, and epidemiological studies. The AURORA project performs observational studies to investigate determinants and health impacts of MNPs by including 800 mother-child pairs from 2 existing birth cohorts and 110 women of reproductive age from a newly established cohort. This will be complemented by toxicological studies using a tiered-testing approach and epidemiological investigations to evaluate associations between maternal and prenatal MNP exposures and health perturbations, such as placental function, immune-inflammatory responses, oxidative stress, accelerated aging, endocrine disruption, and child growth and development. The ultimate goal of the AURORA project is to create an MNP risk assessment framework and identify the remaining knowledge gaps and priorities needed to comprehensively assess the impact of MNPs on early-life health. Results: In the first 3 years of this 5-year project (2021-2026), progress was made toward all objectives. This includes completion of recruitment and data collection for new and existing cohorts, development of analytical methodological protocols, and initiation of the toxicological tiered assessments. As of September 2024, data analysis is ongoing and results are expected to be published starting in 2025. Conclusions: As plastic pollution increases globally, it is imperative to understand the impact of MNPs on human health, particularly during vulnerable developmental stages such as early life. The contributions of the AURORA project will inform future risk assessment. International registered report identifier (irrid): DERR1-10.2196/63176., The authors attest that there was no use of generative artificial intelligence technology in the generation of text, figures, or other informational content of this manuscript. This research was supported by funding from the European Union’s Horizon 2020 research and innovation programme (grant 964827; AURORA project, coordinated by University Medical Center Utrecht). RECETOX was supported by the European Union’s Horizon 2020 research and innovation programme (grant 857560; CETOCOEN Excellence).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Firefighters and the liver: Exposure to PFAS and PAHs in relation to liver function and serum lipids (CELSPAC-FIREexpo study)

  • Pálešová, Nina
  • Maitre, Léa
  • Stratakis, Nikos
  • Řiháčková, Katarína
  • Pindur, Aleš
  • Kohoutek, Jir̂í
  • Šenk, Petr
  • Bartošková Polcrová, Anna
  • Gregor, Petr
  • Vrijheid, Martine
  • Čupr, Pavel
Introduction: Firefighting is one of the most hazardous occupations due to exposure to per- and polyfluoroalkyl substances (PFAS) and polycyclic aromatic hydrocarbons (PAHs). Such exposure is suspected to affect the cardiometabolic profile, e.g., liver function and serum lipids. However, only a few studies have investigated the impact of this specific exposure among firefighters. Methods: Men included in the CELSPAC-FIREexpo study were professional firefighters (n = 52), newly recruited firefighters in training (n = 58), and controls (n = 54). They completed exposure questionnaires and provided 1-3 samples of urine and blood during the 11-week study period to allow assessment of their exposure to PFAS (6 compounds) and PAHs (6 compounds), and to determine biomarkers of liver function (alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) and total bilirubin (BIL)) and levels of serum lipids (total cholesterol (CHOL), low-density lipoprotein cholesterol (LDL) and triglycerides (TG)). The associations between biomarkers were investigated both cross-sectionally using multiple linear regression (MLR) and Bayesian weighted quantile sum (BWQS) regression and prospectively using MLR. The models were adjusted for potential confounders and false discovery rate correction was applied to account for multiplicity. Results: A positive association between exposure to PFAS and PAH mixture and BIL (β = 28.6%, 95% CrI = 14.6-45.7%) was observed by the BWQS model. When the study population was stratified, in professional firefighters and controls the mixture showed a positive association with CHOL (β = 29.5%, CrI = 10.3-53.6%) and LDL (β = 26.7%, CrI = 8.3-48.5%). No statistically significant associations with individual compounds were detected using MLR. Conclusions: This study investigated the associations between exposure to PFAS and PAHs and biomarkers of cardiometabolic health in the Czech men, including firefighters. The results suggest that higher exposure to a mixture of these compounds is associated with an increase in BIL and the alteration of serum lipids, which can result in an unfavourable cardiometabolic profile., This work was funded by the European Union's Horizon 2020 research and innovation program under grant agreement No 857487 and supported under grant agreement No 857340, grant agreement No 857560 and grant agreement No 874627. This work was supported by the project National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES, ID Project No. LX22NPO5104) - Funded by the European Union – Next Generation EU. This work was supported by the European Union's Horizon Europe research and innovation programme in the framework of the European Partnership for the Assessment of Risks from Chemicals (PARC) under grant agreement No 101057014. Views and opinions expressed are however those of the authors only and do not necessarily reflect those of the European Union or the Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.